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Introduction 
Congenital Diaphragmatic Hernia 
   Congenital diaphragmatic hernia (CDH) occurs due to a defect of the diaphragm, 
which occurs in 1.7 to 5.7 per 10,000 live-born infants [Kotecha et al., 2012]. Through 
this opening in the diaphragm, abdominal organs invade the thoracic cavity, causing 
pulmonary hypoplasia and pulmonary hypertension. As a result, respiratory 
insufficiency occurs so patients with such CDH have a high mortality rate. In addition, 
CDH patients tend to present various other morbidities, for example, neurocognitive 
delay, gastroesophageal reflux, hearing loss, chest wall deformity, poor growth, and 
recurrence of hernia [Lally et al., 2008]. 
   Recently the CDH survival rate has reached up to 90% in advanced clinical centers 
[Kotecha et al., 2012]. This increase might be associated with prenatal diagnosis, 
resulting in treatment by specialized multidisciplinary teams immediately after birth. In 
addition, significant progress in postnatal treatment, such as gentle ventilation and 
extracorporeal membrane oxygenation (ECMO), has contributed to an improvement of 
the survival rate in the CDH patients [Jancelewicz et al., 2013; Ssemakula et al., 1997]. 
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As a result, the focus of care has shifted to morbidities, such as recurrence of hernia. 
   One reason for the recurrence is the prosthetic patch that is utilized during the CDH 
repair surgery. When the hernia hole is too large to perform closure, it is closed by a 
prosthetic patch, such as Gore-Tex®. However, the patch cannot be absorbed or merged 
into body; therefore, the recurrence rate in the patched group (14%) is higher than the 
rate in the non-patched group (4%) [Jancelewicz et al., 2013]. To improve this problem, 
some surgeons are using muscle tissue from the patient, for example an abdominal 
muscle flap [Masumoto et al., 2007]. However, the optimal treatment technique for 
recurrent CDH has yet to be determined.  
 
The Possibility of Regeneration Therapy for CDH Treatment 
   In order to treat the recurrence of CDH, diaphragm regeneration therapy using 
skeletal muscle derived progenitor cells, myoblasts (MBs) or myotubes (MTs), can be 
useful. Myoblasts are derived from satellite cells (muscle stem cells) when the muscle is 
damaged and MyoD1 is expressed. After a sufficient number of myoblasts are 
proliferated, the expression of MyoD1 and myostatin (myogenin’s suppressing factor) 
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decreases. This leads to an increase in myogenin expression, and myoblasts fuse 
together to form myotubes; tube shaped multinucleated cells. After the myoblast 
matures, a sarcomere layer shows up, and a skeletal muscle fiber is formed. If a 
recurrent hernia occurs, the hole can be closed by a cell sheet, consisting of myoblasts 
or myotubes from the patient, and the sheet can regenerate the diaphragm while 
growing with the patient. Operative procedures might be simpler and safer if a 
myogenic patch produced by regenerative therapy were to be available. This is simply 
one of the optimistic blueprints proposed for the treatment of CDH.  
   To test this hypothesis, first, the ability of transplanted myoblasts to differentiate 
into skeletal muscle tissues was ensured because skeletal muscle tissue normally repairs 
broken fibers rather than regenerating the entire cell [Saihara et al., 2009]. Through 
transplantation experiments, we hypothesized that the myoblasts could differentiate into 
skeletal muscle tissues spontaneously. The transplanted enhanced green fluorescent 
protein expressing myoblast (EGFP MB) survived and differentiated into the target 
area; however, only in low numbers. It has previously been reported that transplanted 
myoblasts do not survive well, possibly due to cell migration from the target area and 
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cell death from hypoxia and lack of nutrition [Fan et al., 1996; Muttini et al., 2012]. 
Indeed, some improvements to the technique were necessary. Two possibilities were 
considered for this: using basic fibroblast growth factor (bFGF) with cell transplantation 
to improve the target area environment, and transplanting myotubes to stop cell 
migration. 
 
Promotion of Muscle Regeneration by Myoblast Transplantation Combined with 
the Controlled and Sustained Release of bFGF cpr. 
   First, EGFP myoblast transplantation with bFGF that was gradually released by 
gelatin hydrogel microspheres (DDS gel) was tested. One of the most famous bFGF 
effects is the enhancement of angiogenesis [Nakajima et al., 2004; Sakakibara et al., 
2002; Marui A et al., 2005]. The more blood vessels, the better the supply of oxygen 
and nutrients, thus the transplanted cell survival rate should increase. Another reported 
effect of bFGF was neurogenesis [Ikeda et al., 2008]. Without peripheral nerve 
attachment, skeletal muscle tissue usually atrophies. Normally, skeletal muscle 
regeneration takes about 3 weeks. As such, releasing bFGF in the target area for 4 
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weeks is optimal. For this purpose, DDS gel was used. The bFGF that was adhered to 
the gel was released during biodegradation [Sakakibara et al., 2002; Tabata et al., 2008]. 
In this in vivo experiment, three groups were tested: control group 1 (C1) with EGFP 
myoblast transplantation, control group 2 (C2) with EGFP myoblast and DDS gel 
containing phosphate buffer saline (PBS), and experimental group (Ex) with EGFP 
myoblast and DDS gel containing bFGF. Muscle tissue samples from each group were 
collected during the 1st and 4th week after the transplantation. After 10 months, the 
samples were also collected from C1 and Ex to determine long term effects. 
 
Aligned Poly Vinyl Alcohol Micro Pattern Effect on Myogenesis 
   Second, for myotube transplantation, the effects of different cell attachment width 
on myotube formation were studied. Myotubes have a string shape and do not easily 
migrate from the transplanted area like myoblasts. Therefore, myotube transplantation 
may be the optimal choice to substitute prosthetic patches. Naturally, skeletal muscle 
tissues align well to generate high-tension power on one axis. This is present in the 
diaphragm, where the diaphragm skeletal muscles pull the central tendon disk to the 
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thorax. Thus, if the transplanted myotubes were also well aligned, they would not easily 
detach from the target location. However, in vitro, seeded myoblasts make swirling 
myotubes, and a parallel pattern culture surface was necessary to align the myotubes 
[Clarket et al., 1997; Lam et al., 006]. In this experiment, six different cell attachment 
groove widths, 5 µm, 10 µm, 25 µm, 50 µm, 200 µm, and 400 µm, were made using a 
polyvinyl alcohol (PVA) coat, and myoblasts were cultured by differentiation medium 
into myotubes in order to study the culture width effect on myotube formation. 
 
Three Dimensional Aligned Myotube Culture in Collagen Hydrogel on a Patterned 
Calcium Alginate Gel Substrate 
   Third, myoblasts and myotubes were cultured using a collagen gel embedded 
culture method on an aligned calcium alginate gel substrate to make aligned myotubes 
for myotube transplantation. In the collagen gel, cells behave and differentiate 
differently in comparison to cells cultured on a flat culture dish [Yang et al., 1983]. In 
particular, myoblasts can be differentiated into myotubes well [Konigsberg et al., 1960]. 
The collagen gel containing the cells was placed on to the calcium alginate substrate, 
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and the substrate controlled the direction of cell proliferation by its aligned pattern. In 
addition, the substrate supplies oxygen and nutrition to the cells located in the bottom 
area of the collagen gel. The cells do not attach to the hydrogel; thus, only the aligned 
myotubes can be easily detached from the aligning substrate for their transplantation. In 
this study, a calcium alginate substrate with 400 µm aligned ditch patterns was 
constructed; then, the myoblasts containing collagen gel were placed on the substrate 
and cultured. 
 
Summary of Introduction 
   CDH is a life-threatening disease caused by congenital diaphragm defects, and the 
recurrence of hernia in CDH survivors is harmful. This is particularly true when the 
patient requires patch repair because of a large defect; the patch is not absorbed by body 
and increases the recurrent hernia rate. Instead of prosthetic patch, a myotube patch can 
be useful because it can grow with the patient. To achieve this goal, the bFGF effects 
were first tested on angiogenesis and transplanted myoblast survival. Second, the effects 
of the area for cell adhesion for myogenesis were studied by using polyvinyl alcohol. 
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Third, to investigate aligned myotube transplantation, a collagen gel embedded 
myoblast culture method on a calcium alginate substrate with an aligned pattern was 
tested. 
Chapter 1 
 9 
Chapter 1 
Promotion of Muscle Regeneration by Myoblast Transplantation Combined with 
the Controlled and Sustained Release of bFGF cpr. 
1.1. Introduction 
   Regenerative medicine has recently become a treatment choice for a variety of 
diseases. Enhancing muscle regeneration via myogenic cell-based therapy is an 
attractive approach to treat injuries and diseases of skeletal muscle. Satellite cells (SCs) 
are the primary endogenous cells involved in skeletal muscle regeneration and therefore 
are good candidates for the regenerative therapy of injured or diseased muscle. SCs are 
sequestered between the sarcolemma and mature muscle fibers. They do not proliferate 
normally, but begin to proliferate in response to specific local stimuli, such as muscle 
damage. SCs migrate to areas of injury and then differentiate into the muscle precursor 
cells, called myoblasts, which allows them to fuse with pre-existing damaged fibers or 
with each other, and subsequently differentiate into muscle fibers after the myotube 
stage. SCs can be isolated from muscle biopsies via standard cell-culture techniques and 
can be easily expanded in vitro to produce large quantities of myoblasts while 
Chapter 1 
 10 
maintaining their capacity to fuse and to differentiate into myofibers [Konigsberg, 
1960]. As a result, using SC-derived myoblasts has been suggested as a possible 
therapeutic approach for skeletal muscle regeneration [Partridge et al., 1978]. Myoblast 
transplantation has been reported to increase the myogenic capacity of pathological 
muscle following severe muscle damage [Alameddine et al., 1994; Wernig et al., 1995, 
2000]. Furthermore, exogenous myoblasts transplanted to muscle can also provide a 
permanent source of muscle precursor cells [Yao et al., 1993; Heslop et al., 2001]. 
However, cultured myoblasts gradually lose their myogenic potential, and the 
transplantation of these cells induces regeneration with a much lower efficiency 
[Machida et al., 2004; Montarras et al., 2005]. Less than 1% of these SC-derived 
myoblasts survive the first few days after transplantation [Beauchamp et al., 1999; Fan 
et al., 1996]. Thus, although myoblast transplantation is an attractive method of muscle 
regeneration for various muscle diseases, the efficiency of myoblast transplantation is 
not sufficient, as most transplanted myoblasts do not survive or contribute to muscle 
regeneration. 
   Several growth factors may have an impact on the viability and myogenicity of 
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transplanted cells in vivo. In skeletal muscle, basic fibroblast growth factor (bFGF; 
FGF-2) is present in the extracellular matrix surrounding the muscle fibers and can be 
released from focally injured myofibers [DiMario et al., 1989; Clarke et al., 1993]. 
bFGF is expressed at a high level during muscle regeneration, and bFGF injection has 
been shown to improve recovery in reinnervated and dystrophic muscle [Anderson et al., 
1995; Iwata et al., 2006; Lefaucheur and Sebille, 1995]. Furthermore, the addition of 
bFGF to the growth medium prior to implantation improves cell survival [Kinoshita et 
al., 1996]. Neutralizing antibodies to bFGF attenuate skeletal muscle repair [Lefaucheur 
and Sebille, 1995]. Thus, modulations of the endocrine or paracrine effects of bFGF 
contribute to muscle recruitment. bFGF is an activator of SC proliferation, as well as SC 
migration potential [Allen and Boxhorn, 1989; Doumit et al., 1993; Lafreniere et al., 
2004]. It enhances the number of proliferating cells by facilitating the recruitment of 
additional SCs from the quiescent state, followed by a rapid transition to differentiation, 
ultimately stimulating muscle healing in vivo [Yablonka-Reuveni and Rivera, 1997; 
Menetrey et al., 2000]. Thus, bFGF is expected to directly stimulate muscle 
regeneration. Moreover, bFGF has a strong angiogenic effect, which may facilitate the 
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survival of transplanted cells by improving microvascular environments in the host 
[Efthimiadouet al., 2006]. The role of bFGF in muscle regeneration may reside in the 
revascularization process [Lefaucheur et al., 1996]. bFGF-expressing fibroblasts were 
able to induce complex regenerative processes, such as arteriogenesis or myogenesis, in 
injured ischemic muscles [Doukas et al., 2002]. Thus, bFGF appears to act at different 
stages of the SC-mediated regeneration process. 
   On the other hand, it is difficult to achieve site-specific and continuous in vivo 
delivery via the direct administration of growth factors. To resolve the issues of direct 
administration, gelatin hydrogel microspheres have been developed for the targeted 
delivery and controlled release of bFGF [Tabata et al., 1998, 1999a, 1999b]. After 
administration of bFGF-impregnated gelatin hydrogel microspheres to the targeted 
tissue, bFGF is continuously released during the biodegradation of the gelatin hydrogel 
microspheres and is biologically active as a result of in vivo degradation [Tabata et al., 
1998, 1999a, 1999b, 2000; Hosaka et al., 2004]. Its release profile was shown to be 
controllable [Tabata et al., 1999a; Yamamoto et al., 2001]. In the present study, we 
investigated the effect of the controlled and sustained release of bFGF from gelatin 
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hydrogel microspheres following myoblast transplantation to facilitate muscle 
regeneration. 
 
1.2. Materials and methods 
1.2.1. Animals 
   Sprague-Dawley (SD) rats aged 3–4 weeks to be used as recipients and SD-Tg 
(CAG–EGFP) rats aged 1–2 weeks to be used as donors were purchased from Japan 
SLC (Hamamatsu, Japan). The animals were housed in standard cages under specific 
pathogen-free conditions. 
 
1.2.2. Isolation of rat myoblasts with a preplating method 
   Myoblasts were isolated from the hindlimb muscles of SD-Tg rats. Briefly, the 
hindlimb muscles were removed under diethyl ether anesthesia (Wako, Japan), trimmed 
of excess connective tissue and blood vessels, washed with phosphate-buffered saline 
(PBS (-); Nissui Pharmaceutical Co, Japan) and minced with scissors. The hindlimb 
muscle samples were then digested by serial incubations, followed by mixing, at 37in 
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0.1% type I collagenase (Worthington, USA), 2U dispase II (Roche, Germany), 0.05% 
trypsin and 0.2% EDTA for 45, 45 and 30 min, respectively. The cell suspension was 
filtered through a 70 mm cell strainer (Becton–Dickinson, USA) and centrifuged at 
3000 rpm for 5 min. The pellets were then suspended in growth medium Dulbecco’s 
modified eagle’s medium (DMEM)/F-12 Ham (Sigma-Aldrich, USA), supplemented 
with 10% fetal bovine serum (FBS), 10% horse serum and 1% penicillin–streptomycin] 
and plated in type I collagen-coated dishes (IWAKI, Japan). After 1 h, the supernatant 
containing non-adherent cells was withdrawn from the dish and replated in a fresh 
collagen-coated dish. By the final serial plating, the culture was enriched with small 
round cells. This fifth pre-plate population (pp 5 cells) was kept at less than 60% 
confluency as myoblasts. The ratio of myoblasts (cells expressing desmin) was 
approximately 95%. 
 
1.2.3. Preparation of gelatin hydrogel microspheres incorporating bFGF 
   Gelatin hydrogel microspheres were prepared by the chemical crosslinking of 
gelatin in a water-in-oil emulsion state, according to a previously reported method 
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(Tabata et al., 1998, 1999a, 1999b). A 10 ml aqueous solution of 10 wt% gelatin 
(isoelectric point 5.0, weight-averaged molecular weight 100 000; Nitta Gelatin, Osaka, 
Japan) was prepared at 40 and then added dropwise into 600 ml olive oil (Wako, 
Osaka, Japan) while stirring at 40and 400 rpm for 10 min to prepare a water-in-oil 
emulsion. The emulsion was then cooled to 4to allow natural gelation of the gelatin 
solution in order to obtain a non-crosslinked gelatin hydrogel microsphere. To exclude 
residual oil, the resulting microspheres were washed three times with cold acetone and 
homogenizer combined with centrifugation (5000 rpm, 4, 5 min). Next, the 
microspheres were fractionated by size, using cold acetone and sieves with apertures of 
20, 32, 75 and 90 mm (Iida Seiseakusyo, Osaka, Japan), and subsequently air-dried 
overnight at 4. Next, 20 mg 45–75 mm microspheres were stirred in 20 ml 0.1 wt % 
Tween 80 aqueous solution containing 1 ml 25 wt% glutaraldehyde solution at 4 for 
24 h to crosslink the gelatin microspheres. After washing by centrifugation with 
double-distilled and deionized water (DDW), the microspheres were agitated in 20 ml 
of 100 mM aqueous glycine/DDW solution at room temperature to block the residual 
aldehyde groups of glutaraldehyde, and subsequently centrifuged for 5 min at 5000 rpm 
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at 4. This glycine/DDW washing and centrifuging process was applied three times. 
Afterward, the precipitate and 500 ml glycine/DDW solution was stirred for 1 h at room 
temperature and subsequently centrifuged for 5 min at 5000 rpm at room temperature. 
The resulting microspheres were washed with DDW by centrifugation and subsequently 
freeze-dried. Finally, the microspheres were sterilized by ethylene oxide gas for 22 h at 
40 and vacuum-dried for 3 days. Before cell transplantation, 10 µl 1 mg/ml solution 
bFGF or PBS was dropped onto 2 mg freeze-dried gelatin hydrogel microspheres and 
impregnated overnight at 4. Degradation of the gelatin hydrogel microspheres was 
adjusted to approximately 30 days. 
 
1.2.4. Myoblast transplantation to the damaged thigh muscle 
   Forty-eight SD rats were used as recipients. The rats were divided into four groups: 
control group 1 (C1) comprised 14 rats that received myoblasts suspended in 100 ml 
phenol red-free DMEM (Sigma-Aldrich, USA); control group 2 (C2) comprised 14 rats 
that received gelatin hydrogel microspheres containing myoblasts without bFGF; 
control group 3 (C3) comprised 4 rats that received gelatin hydrogel microspheres 
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containing with bFGF; and the experimental group (Ex) comprised 16 rats that received 
gelatin hydrogel microspheres containing 100 µg bFGF and 1.5×107 myoblasts into the 
damaged muscle. From both the C1 and Ex groups, 2 rats were bred for use in a long 
term study (Figure 1). 
   One day prior to surgery, 100 µl PBS with and without 100 µg bFGF was added to 
the gelatin hydrogel microspheres, and the microspheres were incubated at 4 
overnight. Then, myoblasts isolated from the hind limb muscle of 1 week-old SD-Tg 
rats were prepared. A total of 1.5×107 myoblasts/animal were re-suspended in 100 µl 
phenol red-free DMEM, with or without the prepared microspheres, depending on the 
group. 
   About 3 mm × 3 mm of muscle was removed from the thigh of 3–4 week-old SD 
rats with forceps, and the damaged muscle portion was sutured. The wound was then 
sprayed with a transparent sterile and analgesic dressing (Nobecutan L Spray; 
Yoshitomi Chemical, Japan). Next, 100 µl myoblast suspension was injected into 
various locations of the damaged muscle portion using a 1 ml syringe (Terumo, Japan) 
with a 27G 1/2 needle (Nipro, Japan), followed by the injection of 0.64 mg/kg FK506 
Chapter 1 
 18 
(Astellas Pharma Inc, Japan). Finally, the skin was sutured shut. The recipient rats 
received FK506 (0.64 mg/kg) intramuscularly for 7 days after transplantation. The rats 
were euthanized 4 weeks after transplantation and samples of their muscle tissue were 
collected. The samples were washed well with PBS (-) to remove blood because CD31 
also exists in white blood cells. For the long-term study, skeletal muscle samples were 
collected from 2 C1 group rats and 2 Ex group rats at 10 months after transplantation. 
The samples were enclosed in Optimal Cutting Temperature compound 
(O.C.T.Compound, Funakoshi, Japan) and stored at –80 for histological analysis 
[hematoxylin and eosin (H&E), Masson’s Trichrome (MT) and immunofluorescent 
staining]. A small portion of the muscle was also stored in a 1.5 ml Eppendorf tube 
(Hamburg, Germany) at –196 for analysis by qRT–PCR. 
 
1.2.5. Immunofluorescence study 
   Samples from every group were sliced into 8 µm thick sections using a Leica 
CM1850 Cryostat with microtome blades (Leica Microsystems, Germany) and collected 
on Matsunami Adhesive Slide (MAS)-coated Superfrost glass microslides (Matsunami, 
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Japan). The samples were fixed in 4% paraformaldehyde (Wako, Japan) for 20 min at 
room temperature, and their surface tension was reduced by Triton X-100 (Wako, 
Japan) for 5 min at 4. 10% albumin, from bovine serum Cohn Fraction V (BSA; 
Wako, Japan) was used as a blocker for 10 min at room temperature. The samples were 
then treated with the following antibodies for 60 min at room temperature: rabbit 
anti-myosin monoclonal IgG (1:50; Calbiochem, Germany), mouse anti-desmin 
monoclonal IgG (1:50; Dako, Denmark) and mouse anti-GFP monoclonal IgG (1:500; 
Invitrogen, CA, USA). Next, the following antibodies were applied for 60 min at room 
temperature: TRITC-conjugated polyclonal swine anti-rabbit IgG (1:50; 
DakoCytomation, Denmark), TRITC-conjugated polyclonal rabbit anti-mouse IgG 
(1:50; DakoCytomation) and Alexa Fluor® 488 goat anti-mouse IgG (1:400; Invitrogen, 
USA). Nucleus staining and mounting were achieved with Vectashield mounting 
medium with DAPI H-1200 (Vector Laboratories, USA). The samples were then sealed 
using cover glasses (Matsunami, Japan). Between each step, the specimens were 
washed with PBS for 15 min. Finally the stained specimens were visualized using a 
BZ-8100 fluorescent microscope (wavelength of 488 nm for FITC and AlexaFluor® 488, 
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500 nm for TRITC and 372 nm for DAPI; Keyence, Japan) and a BZ-Analyzer 
(Keyence, Japan). 
   The purpose of the immunofluorescent staining was to ascertain of the survival 
(GFP) and location (desmin and myosin) of the transplanted myoblasts. During 
myogenesis and muscle recovery, nuclei on the basal lamina migrated into the muscle 
fiber centers. The percentage of muscle fibers with centralized nuclei was calculated via 
micros- copy, based on the formula:  
(Centralized Nucleus Containing Muscle Fiber %) = [(Number of Muscle Fiber with 
Centralized Nucleus) ÷ (Total Number of Muscle Fiber)] × 100% 
 
1.2.6. qRT-PCR Analysis 
   Total cellular RNA was extracted from frozen samples obtained 4 weeks after 
transplantation with a commercially available RNA isolation kit (Isogen, Nippongene, 
Tokyo, Japan). cDNA was synthesized using 1 mg of total RNA and the GeneAmp 
RNA PCR kit (Roche Molecular Systems, Germany), according to the instructions 
provided by the manufacturer. The cDNA was used for the quantitative real-time 
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polymerase chain reaction (qRT–PCR) analysis on a 7500 Real-Time PCR System 
(Applied Biosystems, CA, USA). Glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH), EGFP and CD31 were measured using the Faststart Universal Prove Master 
(Rox; Roche Applied Science, Germany) and Universal Prove Library (Roche Applied 
Sciencem Germany). β-actin, MyoD1, myogenin, myostatin and Pax7 expression levels 
were measured using Faststart Universal SYBER Green (Roche Applied Science, 
Germany). EGFP was used as a transplanted cell survival marker, and CD31 was used 
as a blood vessel marker. In addition, MyoD1 was used as a marker of myoblast 
proliferation, and myogenin was used as a marker of myoblast differentiation into 
myotubes or myofibers. Myostatin was used as a myogenin suppression marker. Each 
primer was designed based on the nucleotide search engine [National Center for 
Biotechnology Information (NCBI), USA] and the Universal Probe Library Assay 
Design Center (Roche Applied Science, Germany) and synthesized by Hokkaido 
System Science Co, Ltd (Hokkaido System Science Co., Ltd., Japan) (Table 1). For 
both, 20 ml of the solution mixture was applied. The thermal cycling conditions for 
real-time RT–PCR were: 50 for 2 min, 95 for 10 min, 43 cycles at 95 for 15 s 
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and 60 for 1 min. The data from the real-time PCR were calculated using the 
previously described ΔΔCT method (Livak et al., 2001). The initial normalizers were 
GAPDH for Universal Prove Library and β-actin for SYBER Green. 
   All animal experiments were consistent with the University of Tsukuba’s 
Regulations of Animal Experiments, and permitted by the Animal Experiment 
Committee, University of Tsukuba (No. 07-065). 
 
1.2.7. Statistical analysis 
   KeyPlot version 2.0 b15 (KyensLab Inc., Japan) was used for the statistical analysis. 
The analysis was carried out using one-way analysis of variance (ANOVA), followed 
by parametric multiple comparison. All data are expressed as mean ± standard error of 
the mean (SEM). Differences were considered significant at p < 0.05. 
 
1.3. Results 
1.3.1. Muscle regeneration in damaged muscle 
   Four weeks after transplantation, multinucleated cells with a striated muscle 
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structure, expressing myosin and GFP, were observed in C1, C2 and Ex, suggesting 
integration into the host muscle as myofibers; the so-called ’regeneration of muscle’ by 
transplanted myoblasts (Figure 2). In addition, 10 months after the transplantation, 
GFP-positive skeletal muscle was recognized in both C1 and Ex group rats (long-term 
C1 and long-term Ex) (Figure 3). 
 
1.3.2. Improved survival of transplanted myoblasts 
   Four weeks after transplantation, the expression levels of EGFP were compared 
using qRT–PCR. The expression level of EGFP in Ex was significantly higher than that 
in both C1 (p < 0.05) and C2 (p < 0.05) (Figure 4). In addition, the long-term Ex group 
of rats showed a significantly higher EGFP expression than the long-term C1 group (p
0.01; Figure 4). C3 did not contain any EGFP myoblasts; therefore, the EGFP 
expression was not observed. These results demonstrate the improved survival rate of 
transplanted myoblasts in Ex. 
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1.3.3. Promotion of muscle fiber regeneration 
   Many muscle fibers of small caliber surrounded by fibrous connective tissues were 
observed in the regenerating area (Figure 5 and 6). The regenerating muscle fibers were 
characterized by the presence of centrally located nuclei (Figure 5 and 6). The 
percentages of muscle fibers with centralized nuclei were calculated using 
cross-sections of the fibers. The percentage of fibers with centralized nuclei in Ex was 
found to be significantly higher than that in both the C1 (p < 0.001) and C2 (p < 0.05) 
groups 4 weeks after transplantation (Figure 6). The regeneration rate was calculated as 
2.54 by normalizing the percentage of centralized nuclei in Ex with that in C1. This 
result indicates that muscle regeneration was markedly promoted in Ex. C3 also 
demonstrated a significantly higher nucleus centralization rate than C1 (Figure 6). This 
implies that bFGF had a positive effect on muscle regeneration. After 10 months, the C1 
and Ex groups did not show any significant differences. 
 
1.3.4. Promotion of angiogenesis 
   The expression level of CD31 was measured as a marker of vascular endothelium 
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via qRT–PCR analysis. Four weeks after transplantation, the CD31 expression level in 
C3 was significantly higher than the level in C1 and C2 (Figure 7). The expression level 
of CD31 in Ex was higher than that in both C1 and C2, but the differences were not 
significant (Figure 7). There was also no significant difference between C3 and Ex. This 
suggests that the CD31 level in Ex was higher than the level in C1 and C2 but lower 
than the level in C3. After 10 months, Ex group rats showed significantly higher CD31 
expression than C1 group rats (p0.05) (Figure 7). 
 
1.3.5. Effects on the expression of muscle regulatory factors (MRFs) 
   The expression levels of Pax7, MyoD1, myogenin and myostatin were measured via 
qRT–PCR analysis. The expression level of Pax7 in Ex was higher than that of both C1 
and C2, but the differences were not significant, according to parametric multiple 
comparison, even though a one-way ANOVA suggested significant differences between 
the groups (p < 0.01) (Figure 8). The expression level of MyoD1 in Ex was significantly 
lower than that in both C1 (p < 0.01) and C2 (p < 0.001) (Figure 8). In addition, the 
expression level of Myogenin in Ex was significantly higher than that in both C1 (p < 
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0.05) and C2 (p < 0.05) (Figure 8). Moreover, the expression level of myostatin in Ex 
was lower than that of both C1 and C2, but the differences were not significant (Figure 
8). 
 
1.4. Discussion 
   To date, myoblast transplantation has shown limited efficiency in integrating donor 
cells with host muscle [Machidaet al., 2004; Montarras et al., 2005; Beauchamp et al., 
1999; Fan et al., 1996]. During in vivo muscle regeneration, the stem cell niche, growth 
factors, cytokines and neurotrophic factors all play a prominent role. The interaction 
between myoblasts and the surrounding microenvironment is one of the most important 
factors regulating the survival of transplanted myoblasts, so that the strengthening of 
such interactions is necessary to improve the efficiency of myoblast transplantation. 
Several previous studies reported that the administration of free bFGF showed 
considerably less bioactivity due to its short half-life in vivo [Tabata et al., 1999a, 
1999b; Kawai et al., 2000]. In the present study, the efficacy of the controlled and 
sustained release of bFGF on muscle regeneration following myoblast transplantation 
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was evaluated, expecting angiogenetic, as well as myogenic, actions. Three stages of 
muscle regeneration following muscle damage were distinguished: the destruction and 
inflammatory phase (1–3 days), the repair phase (3–4 weeks) and the remodelling phase 
(3–6 months) [Arrington and Miller, 1995; Tidball, 2005]. It should be mentioned that 
the last two phases tend to overlap. In our previous study using the same rat model, we 
could not observe muscle fiber formation derived from transplanted myoblasts by 2 
weeks after transplantation [Saihara et al., 2009]. We evaluated the results of muscle 
regeneration at 4 weeks after myoblast transplantation. Transplanted GFP-positive 
myoblasts survived and contributed to muscle regeneration in C1, C2 and Ex (Figure 2 
and 4). In the present study, the remarkably high expression of EGFP in Ex 4 weeks 
after transplantation showed an obvious improvement in the survival rate of 
transplanted myoblasts via our bFGF delivery system (Figure 4). Ten months after 
transplantation, the EGFP expression in Ex was much higher than in C1 (Figure 4). In 
addition, the average expression in long-term Ex was higher than the average in 4 week 
Ex (Figure 4). This implied that the transplanted EGFP myoblasts survived and 
satisfactorily proliferated in the target area. On the other hand, the expression level of 
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CD31, the vascular endothelial marker, was higher in Ex compared to that in control 
groups, but the differences were not statistically significant 4 weeks after 
transplantation. However, the CD31 in C3 was expressed at levels significantly higher 
than the CD31 in C1 and C3, but not in Ex. This implies that the CD31 level in Ex was 
between C1 and C3. In fact, 10 months after transplantation, the CD31 level in Ex was 
significantly higher than the level in C1. This suggests that the CD31 expression in Ex 
was not low as was the case in C1 and C2. Although sufficient evidence for the 
angiogenetic effects of sustained release of bFGF has previously been shown, such 
angiogenetic effects were not likely to contribute significantly to the improved survival 
rate of transplanted myoblasts in the current study [Tabata et al., 1999b; Nakajimaet al., 
2004; Yasuda et al., 2008]. It is probable that bFGF activated or proliferated the 
transplanted myoblasts more directly during the destruction and inflammatory phase 
(the first few days), which was critical for the survival of the transplanted myoblasts 
[Beauchamp et al., 1999; Fan et al., 1996]. This resulted in the improved survival rate. 
   Muscle damage induces an inflammatory response that ultimately leads to the 
development of fibrous tissue. Histologically, muscle fibers of small caliber surrounded 
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by fibrous tissues were observed in the regenerating area (Figure 5). Newly regenerated 
myofibers are characterized by the presence of centralized nuclei, which distinguishes 
them from pre-existing myofibers, in which the nuclei are positioned at the cell 
periphery. Remarkable centralization of the nuclei in the muscle fibers of the Ex group 
was observed at 4 weeks after transplantation (Figure 5). This suggests that muscle 
regeneration following activation of host SCs is promoted by bFGF. Neither the 
long-term C1 nor Ex showed a significant difference in the abundance of centralized 
nuclei. This could simply be caused by two reasons: the rat's age and the gelatin 
hydrogel microsphere. First, the average lifespan of rats is 3 years. At the 10th month, 
the rats had already matured; therefore, there was no major increase in skeletal muscle 
tissue. Second, the gelatin hydrogel microsphere was designed for 4 week controlled 
release. Thus after 10 months, the hydrogel had released all of the bFGF.  
   Quiescent SCs expressing Pax7 migrate to the site of injury, upregulate MyoD1 and 
Myf5 and become proliferative [Smith et al., 1994; Yablonka-Reuveni and Rivera, 
1994; Cooper et al., 1999; Beauchamp et al., 1999]. At this point, SCs are also known 
as myoblasts. Subsequent differentiation of the myoblasts is marked by the down 
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regulation of Pax7 and upregulation of Mrf4 and Myogenin [Zammit et al., 2004; Smith 
et al., 1994;Yablonka-Reuveni and Rivera, 1994]. Ultimately, these differentiated 
myoblasts form multinucleated myofibers or fuse to damaged myofibers to regenerate 
the muscle [Chargé and Rudnicki, 2004]. However, some of the activated SCs do not 
proliferate or differentiate, but instead self-renew and replenish the satellite cell pool, 
which is a unique and crucial property of all stem cells [Zammit et al., 2004; Montarras 
et al., 2005]. 
   The expression levels of muscle regeneration factors (MRFs) involved in the 
specification of the skeletal muscle were investigated in the regenerated muscle 4 weeks 
after transplantation. Pax7 was expressed well in Ex, but the difference was not 
significant. This increased Pax7 expression without MyoD1 expression may suggest the 
continuing activation of SCs by the sustained release of bFGF. Myogenin expression 
was significantly increased, while MyoD1 expression was significantly decreased. In 
muscle regeneration, MyoD1 is expressed first, followed by myogenin expression as the 
myoblasts progress through differentiation. The idea that bFGF promotes the 
proliferation of SCs is widely accepted [Allenand Boxhorn, 1989; Doumit et al., 1993]. 
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On the other hand, many previous in vitro studies have shown that bFGF suppresses 
myogenic differentiation [Allen and Boxhorn,1989; Clegg et al., 1987; Hannon et al., 
1996]. However, regeneration in vivo appears to be more complex because of the effects 
of circulatory and intercellular communications. Other reports have demonstrated that 
bFGF can promote subsequent myogenic differentiation in vivo [Yablonka-Reuveni et 
al., 1999; Menetrey et al., 2000]. The SCs that proliferate and express MyoD1 in the 
presence of bFGF are committed to a rapid transition into the myogenin positive state 
and differentiation [Yablonka-Reuveni et al., 1999]. Menetrey et al. (2000) studied the 
effect of various cytokines on muscle regeneration in vivo and found that bFGF 
stimulated both myoblast proliferation and fusion [Menetrey et al., 2000]. In the present 
study, an increase in the expression levels of Myogenin, which marks the onset of 
myogenic differentiation, and a decrease in the expression of MyoD1, which is a marker 
for the activation and proliferation of SCs, were observed at 4 weeks after 
transplantation; the later stage of muscle repair [Zammit et al., 2006]. Therefore, it was 
speculated that the activated myoblasts passed through the MyoD1-expressing state via 
the sustained exposure to bFGF, and entered the myogenin-expressing state at this point. 
Chapter 1 
 32 
These SC-derived myoblasts then became committed to differentiation and fused into 
myotubes. The increased myogenin expression and decreased MyoD1 expression found 
in the current study reflects the promoted process of myotube formation from 
myoblasts. 
   Mitchell et al. (1996) reported that the short biological half-life of administered 
bFGF may limit its effect in stimulating SCs in the process of muscle healing [Mitchell 
et al. 1996]. They also hypothesized that bFGF levels might be adequate in healing 
muscle tissues and are not the limiting factor at the early end point (10 days after injury) 
of the repair phase. On the other hand, Kasemkijwattana et al. (2000) reported that 
repeated injections of bFGF promoted muscle healing [Kasemkijwattana et al. 2000]. In 
the process of muscle regeneration, the cell cycles of SCs are not all synchronized. 
Accordingly, not all SCs can be stimulated by transient exposure to bFGF. Conversely, 
SCs at different stages of the cell cycle in the regenerating tissues can be sequentially 
exposed to bFGF by its sustained release. This continuous stimulation of SCs through 
the inflammatory, to the repair phases, may lead to the promotion of muscle 
regeneration observed in the current study. 
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Figure 1. Experimental Procedure. From EGFP rat’s hind limbs, EGFP skeletal muscle tissues were 
collected; then, EGFP myoblasts were isolated from the tissue (a). After removing a small portion of the 
left hind limb, skeletal muscle tissue was removed (b, c), and the muscle tissue was sutured (d). Then, the 
EGFP myoblasts and/or DDS gel with bFGF were injected into the sutured area (e). (f) shows the target 
area 4 weeks after transplantation. 
 
Table 1. Sequences of the primers used for PCR 
 
* UPL, universal prove library. *NCBI sequence Accession No. 
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Figure 2. Immunofluorescence in the regenerated muscle region. Integration of GFP-positive transplanted 
cells (a) into the myosin-positive muscle (b) was observed at 4 weeks after transplantation. (c) shows the 
merged picture of a and b. The existence of sarcomeres is implied as the tissue was a matured skeletal 
muscle. The scale bars referred to 100 µm. 
 
 
 
 
a 
b 
c 
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Figure 3. Immunofluorescent study in the transplanted area after 10 months. In the experimental group, 
the transplanted GFP positive skeletal muscle tissues and cells (arrow) were found (a, b). Each green, red, 
and blue color represents to GFP, myosin-TRITC, and nucleus-DAPI.  
 
a 
b 
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Figure 4. Relative gene expression levels of EGFP in the transplanted tissues in the experimental group 
and control groups determined by qRT–PCR. The expression level of EGFP in the experimental group 
was significantly higher than that in the control groups 4 weeks after GFP- positive myoblast 
transplantation. EGFP myoblasts were not transplanted into the control group 3. After 10 months, both 
C1 and Ex EGFP expression levels were increased, but Ex EGFP expression was significantly higher than 
C1. Data are presented as the means ± the standard error of the mean (SEM). The * and ** refer to p < 
0.05 and p < 0.01, respectively. 
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Figure 5. Evaluation of regenerating muscle fibers by Masson’s trichrome (MT (A–C) and by 
immunofluorescent staining (D–F). The regenerated areas were located around fibrous tissues 
surrounding muscle fibers (stained blue by MT). The regenerating muscle fibers with their smaller caliber 
and centrally located nuclei (shown by arrows) were observed in the cross-sections of the control groups 
1 (A, D) and 2 (B, E) and the experimental group (C, F, G). After 4 weeks, regeneration of very thin 
myofibers with centralized nuclei were observed, especially in the experimental group (G). 
 
G 
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Figure 6. The graph of the muscle fiber nucleus centralization rate. The percentage of muscle fibers with 
centralized nuclei was significantly increased in the experimental group compared with both of the 
control groups, 1 and 2, 4 weeks after transplantation. Control group 3 demonstrated a significantly 
higher nucleus centralization ratio than control group 1. After 10 months, there were no significant 
differences between C1 and Ex groups. Data are presented as the means ± the standard error of the mean 
(SEM). The * and ** refer p < 0.05 and p < 0.01 respectively. 
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Figure 7. Relative gene expression of CD31. CD31 was expressed well in C3 in comparison with the C1 
and C2. The expression level of CD31 in the experimental group was higher than that in both of the 
control groups, but the differences were not statistically significant. There was a significant difference 
between the C1 and Ex1 after 10 months. Data are presented as the means ± the standard error of the 
mean (SEM). The * and ** refer to p < 0.05 and p < 0.01, respectively. 
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Figure 8. Relative gene expression levels of PAX7, MyoD1, Myogenin, and Myostatin in the 
regenerating muscle. Data are presented as the mean ± the SEM. The *, **. and *** refer to p < 0.05, p < 
0.01, and p < 0.005, respectively. 
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Chapter 2 
Aligned Polyvinyl Alcohol Micro Pattern Effect on Myogenesis 
2.1. Introduction 
   Around the world, many patients are suffering from various muscular disorders or 
injuries, and medical doctors and scientists have been struggling to treat them. There are 
several approaches to treating these diseases. Regenerative medicine is one of them and 
is hoped to eventually treat these problems, especially in young children and infants. In 
comparison with artificial materials, cells or tissues transplanted into defective areas can 
adjust their size as their host grows. For example, diaphragmatic hernia is a congenital 
anomaly occurring in one in approximately three thousand newborns in which a portion 
of the diaphragm is missing [Kotecha et al., 2012]. A neonate suffering from 
diaphragmatic hernia can die due to respiratory failure; therefore, the hole must be 
patched with an artificial material, such as Gore-Tex®. This remedy can be lifesaving; 
however, an artificial material does not extend as its host grows, stunting lung growth 
and resulting in chronic respiratory distress or, rarely, recurrent diaphragmatic hernia 
[Tsai et al., 2012]. 
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   As such, regenerative therapies for muscle are being developed; but, have proven 
problematic. Transplanting only muscle precursor cells, for instance skeletal muscle 
myoblasts, into a target area does not effectively regenerate the muscle defect due to the 
death of the transplanted cells [Fan et al., 1996]. In order to improve this problem, 
myoblast sheet patches have been studied. This remedy is very effective in reinforcing 
the target regional muscle but is still too weak to substitute myotubes or myofibers in 
the target region [Hoashi et al., 2009; Sawa et al., 2012]. Even in Acomys, the first 
mammal to demonstrate high regenerative potential, skeletal muscle regeneration was 
difficult, despite the ability of the rodent to regenerate many tissues like salamanders 
[Seifert et al., 2012]. This fact may suggest that additional support, such as adequately 
differentiated myotube tissue or muscle fiber transplantation, is necessary to regenerate 
the damaged skeletal muscle. However, skeletal muscle has an aligned structure. 
Therefore, if myotube transplantation is to be considered, controlling the myotube 
direction is necessary. 
   For some time, scientists have been trying to align muscle cells using various 
techniques; for example, template shape control, stretching substrate, fluid force, and 
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magnetic force control [Altomare et al., 2010; Vozzi et al., 2010; Gauthaman et al., 
2013; Yamamoto et al., 2009; Tourovskaia et al., 2006]. Some scientists have been 
using polyvinyl alcohol (PVA) to make micro patterns using photolithography 
[Kawazoe et al., 2009; Song et al., 2011]. Cells and proteins cannot adhere to the PVA 
surface; thus, even at nanometer level height, PVA modification can control the cell 
adhesive area. By limiting the cell adherent area, the cell differentiation rate was also 
controlled [Song et al., 2011; Thery et al., 2010]. Myoblasts can also differentiate into 
adipocytes and osteocytes [Kaji et al., 2013]. However, by using an extended-rectangle 
as the adherent area, both the osteogenic and adipogenic differentiation pathways can be 
suppressed [Peng et al., 2010].  
   In the present study, aligned PVA ridges and polystyrene substrate widths were 
controlled at 5 µm, 10 µm, 25 µm, 50 µm, 200 µm, and 400 µm. In theory, this would 
make the cell densities in each width ditch equal. [Kawazoe et al., 2009]. This is 
important because cell density affects the cell differentiation rate and aggregation 
[Kawazoe et al., 2009; Lam et al., 2006; Lu et al., 2009]. On these patterns, myoblasts 
were cultured in a myoblast-myotube differentiation-inducing medium for 14 days 
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while being analyzed. 
 
2.2. Materials and Methods 
2.2.1. Photomask 
   A patterned photomask was designed using a patterned chromium layer on a glass 
slab, as previously reported [Lam et al., 2006; Yang et al., 1983]. The patterned area 
was a 10 mm x 20 mm rectangle including six different pattern width sections: 400 µm 
× 1000 µm, 200 µm × 1000 µm, 50 µm × 1000 µm, 25 µm × 1000 µm, 10 µm × 1000 
µm, and 5 µm × 1000 µm striped areas. 
 
2.2.2. Synthesis of Azidophenyl-Derived Poly (vinyl alcohol) 
   Azidophenyl-derived polyvinyl alcohol (AzPhPVA) was synthesized by coupling 
the hydroxyl groups of PVA to 4-azidobenzoin acid, as previously reported [Lam et al., 
2006; Yang et al., 1983]. The AzPhPVA was cross-linked by ultra violet light radiation. 
 
2.2.3. Micropatterning of Poly (vinyl alcohol) 
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   Polystyrene plates were cut from a tissue culture flask (BD Falcon, USA), and 
0.3mg/ml AzPhPVA solution was applied to each at 0.03 mg/cm2 (Figure 9). The 
AzPhPVA-coated plates were dried in a dark box at room temperature for one day. 
After the dried plates were covered with the photomask, they were exposed to 0.2 J/cm2 
ultraviolet (UV) light by a FUNA-UV LINKER FS-1500 (Funakoshi, Japan). At this 
time, only UV-radiated AzPhPVA was fixed on the polystyrene plate surfaces as PVA. 
In order to remove the unreacted AzPhPVA, the plates were washed by deionized 
distilled water and an ultrasonic machine three times for 60 min each.  
 
2.2.4. Preparation for Cell Culture 
   To prevent leakage of the cell suspension, medical grade silicone, Scar Fix (Dr. 
More, Japan), was cut into a frame shape with 27 mm × 15 mm as an empty space. The 
silicone frames and the patterned PVA plates were sterilized with 70% ethanol for 30 
min, and a silicone frame was placed on each patterned PVA plate in a 60 mm tissue 
culture dish (BD Falcon, USA). The frame-plate sets were dried in a clean bench 
overnight, which resulted in tight adherence. 
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2.2.5. Cell Culture 
   Five thousand L6 rat skeletal muscle cells/cm2 (ATCC, USA) were seeded on the 
framed plates with the differentiation medium: Dulbecco's Modified Eagle's Medium 
F12/Ham (Sigma, USA) including 2% horse serum (Gibco, USA) and 1% penicillin 
streptomycin (Wako, Japan). After 24 hours incubation in 5% CO2 at 37°C, the silicone 
frames were removed, and the medium was replaced with 7 ml of differentiation 
medium. For a period of seven days, the medium was replaced every other day. After 
the 7th day, the medium was exchanged daily and cultured for up to 2 weeks. Samples 
were taken for analysis on the 1st, 2nd, 3rd, 4th, 7th, 10th, and 14th days after seeding. 
 
2.2.6. Immunofluorescent staining 
   After each incubation period, the samples were fixed with 4% paraformaldehyde 
(Wako, Japan) at room temperature, permeabilized with Triton X-100 (Sigma, USA) at 
4, blocked with 2% albumin bovine serum (BSA; Sigma, USA) / phosphate buffer 
saline (-) (PBS (-); Nissui Pharmaceutical Co, Japan), incubated at room temperature 
with the first antibody mixture: 1:60 anti-myosin rabbit polyclonal antibody 
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(Carbiochem, USA) and 1:60 anti-myogenin mouse polyclonal antibody (GeneTex, 
USA), and then the second antibody mixture: 1:60 anti-rabbit swine TRITC 
(Sigma-Aldrich, USA) and 1:200 anti-mouse donkey Alexa Fluor® 488 (Invitrogen, 
USA). Hoechst 33342 (AnaSpec Inc, USA) was used as a nuclear counterstain at room 
temperature, and the samples were then preserved with Fluor Save Reagent 
(Calbiochem, USA) and micro cover glasses (Matsunami, Japan). For F-actin staining, 
myoblasts were incubated at room temperature with 1:40 Alexa Fluor® 555 - Phalloidin 
(Invitrogen, USA) / 1% BSA (Sigma, USA) containing PBS (-) (Nissui Pharmaceutical 
Co, Japan) for 30 min after the permeabilization process. Between each step, the 
samples were washed with PBS (-) for 15 minutes. Myosin, myogenin, and Hoechst 
33342 (Life Technologies, USA) staining were used to ensure myotube formation, 
myotube maturation, and nucleus distribution, respectively. Fluorescent microscopic 
images were taken with a Biozero BZ-8100 (Keyence, Japan), and 360 nm, 480 nm, and 
560 nm wavelength lights were used for each Hoechst 33342, Alexa Fluor® 488, and 
TRITC stained sample, respectively. The images were merged using Biovision 
(Keyence, Japan). 
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2.2.7. Myoblast Orientation 
   Images of the myoblasts were taken on the 1st, 2nd, and 3rd days with a 
phase-contrast microscope (Olympus, Japan), and cell angles were measured using 
Image J (National Institute of Health, USA). The angles were classified into 7 groups 
based on the pattern width: 5 µm, 10 µm, 25 µm, 50 µm, 200 µm, 400 µm, and flat 
(control group which did not have any patterns). In addition, myoblasts in the 200 µm  
and 400 µm width patterns were further separated into “side” and “center” groups. The 
“side” group myoblasts existed within the 50 µm areas from the PVA walls. The “center” 
group myoblasts were located in the remaining central area. The center area for the 200 
µm section was a 100 µm area, and the 400 µm was a 300 µm area. The angles of the 
myoblasts in all groups were measured, and their orientation angles were calculated by 
the following equation. A low orientation angle implied that the MB was parallel to its 
PVA pattern angle.  
(myoblast orientation angle)° = | (PVA pattern angle) ° - (measured angle) °| 
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2.2.8. Myotube Orientation 
   The angles between the horizontal base line and each right side line of the myotubes 
were measured as myotube angles (Figure 10). The PVA pattern angle was also 
measured. The myotube orientation angle was calculated using the equation below. 
(myotube orientation angle)° = | (PVA pattern angle) ° - (measured myotube angle) °| 
 
2.2.9. Myoblast Proliferation Rate 
   On the 1st, 2nd, and 3rd days after seeding, myoblast images were taken in the same 
locations with a phase-contrast microscope, and the cell number was counted. The 
proliferation rate between the 1st and 2nd days and the rate between the 2nd and 3rd 
days in each area were calculated with the following equations: 
(Proliferation Rate between 1st and 2nd in area A) = [(the number of myoblast from the 
2nd day, are A) ÷ (the number of myoblast from the 1st day, are A)] × 100 
(Proliferation Rate between 2nd and 3rd in area A) = [(the number of myoblast from the 
3rd day, are A) ÷ (the number of myoblast from the 2nd day, are A)] × 100 
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2.2.10. Myogenin Expression Rate 
   The numbers of nuclei and myogenin expressing nuclei were counted in randomly 
selected pictures, and the percentage of myogenin expressing nuclei was calculated for 
each image using the equation below (Figure 11).  
(Myogenin expression rate) = [(number of myogenin expressing nucleus) ÷ (number of 
nucleus)] × 100 
 
2.2.11. Myotube Width 
   After myosin-TRITC staining, the widths of myotubes on the 5 µm, 10 µm, 25 µm, 
50 µm, 200 µm, and 400 µm patterns were measured using a fluorescent microscope 
BZ-8100 (Keyence, Japan) and Image J (National Institute of Health, U.S.A) (Figure 
10). From the measured myotube widths for each pattern, the average widths of the 50 
thickest myotubes were also calculated.   
 
2.2.12. Statistical Analysis 
   All data were statistically analyzed with Kyplot 2.0 (KyensLab Inc., Japan). The 
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error bars in every graph are associated with the standard error of the mean, and 
significant differences were calculated through one-way analysis of variance (ANOVA) 
tests and multiple comparison tests (Turkey or Turkey-Kramer). *, **, and *** refer to 
p0.05, p0.01, and p0.005, respectively. 
 
2. 3. Results 
2.3.1. Patterned PVA Plate 
   The patterned PVA was fixed onto a polystyrene plate (Figure 12). Through atomic 
force microscopy, the height of the PVA pattern was measured at approximately 50 nm.  
 
2.3.2. Cell Morphology 
   Seeded L6 myoblasts adhered in the polystyrene ditches and fused together to form 
aligned myotubes. This did not occur with cells seeded onto a flat surface plate (control 
group) (Figure 13, 14, 15, 16, 17, and 18). The existence of myotubes was determined 
by anti-myosin heavy chain (MHC) immunofluorescent staining. Myoblasts and some 
other cells, for example aenothereal cells, neural cells, tendinous cells, osteoblasts, and 
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chondrocytes, do not express MHC. Myotubes at the end of the pattern became very 
thick in order to support the myotubes in the ditches; however, tendon-like cells or 
tissues were not observed. During the myoblast stage, myoblasts in narrower ditches, 
such as the 5 µm, 10 µm, and 25 µm widths, demonstrated a spindle shape along the 
PVA borderline: On the other hand, the cells in the wider sections and flat control 
surface groups showed an extended flat shape, except in the PVA borderline areas.  
   From the 4th day, myoblasts had fused together to form myotubes, and 4 myotube 
shapes were observed: thin fiber, thick fiber, nodular shape, and comb shape (Figure 19). 
Thin fiber myotubes were dominant in every width pattern (Figure 19a) and were often 
observed between the 4th and 7th days. The myotubes thickened in proportion to their 
culture period and formed thick myotubes (Figure 19b). Those thick myotube fibers 
were usually observed in 200 µm and 400 µm width ditches. Sometimes, the myotubes 
would locally thicken and form a nodular shape (Figure 19c). The nodular myotubes 
contained numerous nuclei and some demonstrated a spontaneous rhythmic contraction. 
The average contraction rate per minute was 51.6 ± 7.93. In the 5 µm and 10 µm width 
patterns, myotubes tended to fuse together over ridges to neighboring ditches and form 
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horizontal cteno-shaped myotubes at their joints (Figure 19d). These thin myotubes ran 
from one cteno joint to another (Figure 19d).  
 
2.3.3. Myoblast Orientation 
   During the myoblast stage, myoblasts, particularly those in the 10 µm and 25 µm 
width ditches, aligned well (Figure 20, 21, 22, and 23). Throughout the myoblast stage, 
(the 1st, 2nd, and 3rd days) the average myoblast orientation angles in the flat control 
were 44.71°, 48.70°, and 44.66° respectively, which were significantly higher than 
those in the patterned sections in each period (Figure 21, 22, and 23). On the 1st day, 
myoblasts in the 200 µm and 400 µm ditches were more randomly orientated than those 
in narrower patterns (Figure 21). Myoblasts displayed the optimal alignment on the 1st 
day in the 10 µm (4.31°), followed by the 5 µm (6.58°) width sections. On the 2nd day, 
the myoblasts in the 5 µm sections proliferated and connected to their neighboring 
myoblasts; as a result, their average orientation angle decreased slightly (Figure 21 and 
22). Except in the 5 µm sections, every section demonstrated better myoblast orientation 
angles than those on the 1st day. The average orientation angle in the 10 µm sections 
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was 3.79°. This was significantly lower than every other section, with the exception of 
the 25 µm. On the 3rd day, the average myoblast orientation angles in the 5 µm, 10 µm, 
200 µm, and 400 µm sections increased, but those in the 25 µm and 50 µm decreased 
slightly (Figure 23). The lowest of all orientation angles on the 3rd day was 4.89° in the 
10 µm sections. Overall during the myoblast stage, the 10 µm sections demonstrated the 
best average orientation angle. 
   From the results, the myoblasts in the wider sections, such as 200 µm and 400 µm, 
did not align well compared to the narrower sections; however, the myoblasts located 
along the PVA edge line demonstrated a lower orientation angle than those of the 
central areas. During their myoblast stage, the average of the “side” group orientation 
angles in both the 200 µm and 400 µm sections were much lower than that of the 
“center” group (Figure 24 and 25). In addition, the average orientation angles for the 
200 µm and 400 µm “side” groups, along with the 200 µm and 400 µm “center” groups, 
decreased in proportion to time. The “side” groups of the 200 µm and 400 µm sections 
demonstrated similar diminution rates, but the rate for the “center” group of the 400 µm 
pattern was much lower than that of the 200 µm “center” group. 
Chapter 2 
 55 
2.3.4. Myotube Orientation 
   During the 4th, 7th, 10th, and 14th sampling days, the myotubes in every section 
aligned considerably better than those on the flat surface (Figure 26 and 27). On the 4th 
day, 10 µm, 25 µm, and 50 µm sections produced myotubes that were significantly 
better orientated than the 200 µm and 400 µm ones (Figure 26). On the 7th day, in the 5 
µm and 10 µm sections, myotubes fused to the ones in the neighboring ditches, while 
myotubes in the 25 µm and 50 µm sections showed obviously lower orientation angles 
than those in 200 µm and 400 µm sections (Figure 26). On the 10th day, the orientation 
angles in the 400 µm sections decreased; however, the best-aligned myotubes were still 
observed in the 50 µm section (Figure 27). On the 14th day, myotube aggregation was 
often observed in all sections and confused the average orientation angle for each 
pattern (Figure 27). As a result, except for the flat control, there were no significant 
differences between the sections. Overall, the 25 µm and 50 µm sections produced 
better aligned myotubes than any of the others. 
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2.3.5. Myoblast Proliferation Rate 
   The myoblast proliferation rate in each section did not show obvious differences 
between the 1st and 2nd day; however between the 2nd and 3rd day, the myoblasts in 
the 10 µm, 25 µm, and 50 µm sections showed a lower average cell proliferation rate 
than those in the 5 µm, 200 µm, 400 µm, and flat control sections (Figure 28). In 
particular, the 10 µm sections demonstrated a significantly lower rate than the 5 µm and 
200 µm ones, and the rate in 25 µm was certainly lower than that of the 5 µm. 
 
2.3.6. Myogenin Expression Rate 
   In general, the myogenin expression rate gradually increased until the 7th day and 
then decreased afterward (Figure 29 and 30). On the 4th day, the rate was significantly 
higher in the 25 µm pattern in comparison with the 5 µm and 200 µm patterns (Figure 
29). On the 7th day, the 25 µm pattern demonstrated an obviously higher rate than the 5 
µm and flat control (Figure 29). In addition, the 50 µm pattern showed more myogenin 
expression than the flat control. On the 10th day, the rate in the 25 µm section was still 
higher than that of the 400 µm and flat control pattern (Figure 30). However on the 14th 
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day, there were no significant differences between each group (Figure 30). 
 
2.3.7. Myotube Width 
   In general, the myotubes grew thicker in width until the 10th day and then decreased 
afterward (Figure 31a). On the 4th, 7th, 10th, and 14th, the widest average myotube 
widths were found in the 50 µm, 200 µm, 400 µm, and 400 µm width ditches, 
respectively; and the narrowest were found in the 5 µm, 10 µm, 5 µm, and 5 µm width 
ditches, respectively (Figure 31a).  
   The number of myotubes increased in proportion to the ditch width (Figure 32). In 
particular, in the 200 µm and 400 µm width ditches, there were many thin myotubes  
that decreased the average myotube width (Figure 31a).  
   In order to determine the real myotube width tendency, from every three hundred 
myotubes measured, the thickest fifty myotubes in each group were chosen and their 
averages were calculated. On the 4th day, 50 µm width ditches produced thicker (5.855 
µm) myotubes than other widths (Figure 31b). On the 7th day, the ditches that produced 
thin myotubes were the 200 µm width (77.71 µm) and 400 µm width patterns (81.94 
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µm) (Figure 31b). On the 10th day, 400 µm width ditches formed very thick myotubes 
(123.1 µm). On the 14th day, myotubes in the 10 µm (73.34 µm) and 400 µm width 
ditches (66.82 µm) were wider than the others (Figure 31b). Throughout the culture 
period, the myotube widths in the 5 µm width ditches were lower than those in the other 
ditches (Figure 31b).  
   In addition, the graph of the fifty widest average myotube widths implies a change 
in myotube width tendency in some ditches, such as the 5 µm vs. 10 µm and 25 µm vs. 
50 µm width patterns. In the 5 µm and 10 µm ditches, the myotube width increased in 
proportion to the culture period (Figure 31b). However in the 25 µm and 50 µm width 
ditches, myotube width did not change significantly after the myotubes reached a width 
of around 50 µm (Figure 31a).  
 
2.3.8. Myotube Numbers in one Ditch 
   The numbers of myotubes in each ditch of the 25 µm, 50 µm, 200 µm and 400 µm 
patterns were measured (Figure 32). Myotubes crossed over the ridges in the 5 µm and 
10 µm width patterns; therefore, the data was not measured for these. In the 25 µm 
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width ditches, the average number of myotubes on the 4th, 7th, 10th, and 14th days 
were 1.54, 1.33, 1.18, and 1.50, respectively. On the 10th day the number of myotubes 
was significantly lower than on the 4th and 14th days. In the 50 µm width ditch, the 
number of myotubes on the 4th, 7th, 10th, and 14th days were 3.01, 2.44, 1.63, and 2.49, 
respectively. The number on the 4th day was significantly higher on the 7th, 10th and 
14th days; while the number on the 10th day was significantly lower than that of the 
other days. In the 200 µm width ditch, the number of myotubes on the 4th, 7th, 10th, 
and 14th days were 10.94, 9.97, 5.63, and 7.21, respectively. The numbers on the 4th 
and 7th days were significantly higher than on the 10th and 14th days; while the number 
on the 10th day was significantly lower than that of the 4th, 7th and 14th days. In the 
400 µm width ditch, the numbers of myotubes on the 4th, 7th, 10th, and 14th days were 
25.35, 16.13, 9.91, and 11.56, respectively. The numbers on the 4th and 7th days were 
significantly higher than on the 10th and 14th days. These data highlight two important 
features. First, the narrower patterns have a lower number of myotubes. Second, the 
number of myotubes decreased in proportion to the culture period by the 10th day due 
to the myotubes fusing together. Then, the numbers increased by the 14th day.  
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2.4. Discussions 
   During the myoblast stage, the differences in cell orientation according to their 
adhesion area were obvious. Previously, researchers reported that the cell orientation 
angle decreased in proportion to the pattern width [Dunn et al., 1986; den Braber et al., 
1996]. The limits of the cell adhesive area aligned the actin filaments and microtubules; 
as a result, the cells were aligned well [Wo ́jciak-Stothard et al., 1995; Ohara et al., 
1997; Chen et al., 2009]. Controlling the adhesive area shape could also control the 
orientation of the cell division axis [Chen et al., 2009]. When the cell adhesive area was 
rectangular, the cells divided toward each end of the rectangle [Chen at al., 2009]. The 
result of our study was almost the same to these reports. At first, the 5 and 10 µm 
sections aligned well, and the wider sections showed more random cell orientation in 
proportion to ditch widths. Then, in every pattern, the myotubes decreased their 
orientation angles during proliferation, except for in the 5 µm sections and flat control 
patterns. The 5 µm sections were too narrow for the myoblast size; as a result, the 
daughter cells bridged into the neighbor ditches. At that time, the bridge cells still kept a 
connection to their mother cells and increased the orientation angle. In contrast, on the 
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flat control surface myoblasts could adhere and proliferate in any direction. In 
conclusion, the orientation angles were always random throughout the myoblast stage. 
These results imply that the adhesive area and direction can control the cell shapes. Yet, 
the existence of a borderline itself might be able to control the myoblast orientation. 
   Although the myoblast average orientation angles in the 200 µm and 400 µm ditches 
were high, myoblasts proliferating close to the PVA boundary lines aligned well (side 
groups) in comparison with the myoblasts that were further from the boundary lines 
(center group; Figure 24 and 25). The side group myoblasts in both the 200 µm and 400 
µm ditches had favorably aligned based on their culture periods. Even the center group 
in the 200 µm ditch decreased slightly in proportion to the culture period. However, the 
center group in the 400 µm ditch did not show such differences. This implies that the 
distance from a straight borderline can affect cell alignment. 
   When the cell density became high, myogenin, one of the myogenesis driving forces, 
was expressed in the nucleus, and the myoblasts fused together to form myotubes. 
Before the 10th day, the myogenin expression rate in the 25 µm ditch was significantly 
higher than the rate in the 5 µm, 200 µm, and 400 µm ditches. The myogenin 
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expression rate in the 50 µm ditch demonstrated a similar rate to that of the 25 µm. 
However, the myogenin expression rate in the 50 µm ditches was slightly lower than 
that of the 25 µm. Generally, myogenin was expressed by every myoblast in every 
width of ditch; however, there were several differences based on their environments (the 
width of the ditch). One possible reason for the differences was the myoblast density. In 
the differentiation medium, myoblasts tended to proliferate without migrating; thus in 
narrower ditches, the cell density increased locally as a spot shape. It is also known that 
the direction of the cell division axis elongated along the cell adhesive area shape axis 
[Chen et al., 2009]. When myoblasts recognized the high confluency, one of the 
proliferation factors, MyoD1, decreased, and the cells stopped proliferating [Olson, 
1992]. Subsequently, the expression rate of myostatin, a myogenin suppressor, was 
decreased. Finally, myogenin was expressed in order to enhance cell fusion [Rios et al., 
2002; Geng et al., 2009; Dong et al., 2013; Seiliez et al., 2012]. Between the 1st and 
2nd days, cell proliferation rates for every width of ditch were similar; however, the rate 
between the 2nd and 3rd differed (Figure 28). The cells in the 10 µm, 25 µm, and 50 
µm ditches demonstrated lower proliferation rates than the others (Figure 28). The flat 
Chapter 2 
 63 
control, 200 µm, and 400 µm ditches still contained open spaces, and the myoblasts in 
the 5 µm ditch proliferated over their original ditch wall and into their neighboring 
ditch; as a result, their MyoD1 expression rates were possibly not yet suppressed. On 
the other hand, the myoblasts in the 10 µm, 25 µm, and 50 µm ditches were locally 
packed; thus, their proliferation rates became low. However, even when packed, the 
myoblasts in the 10 µm ditch were not surrounded by cells; as a result, the cells in the 
10 µm ditch might not have suppressed myostatin in order to begin fusing together. The 
ditches being packed with cells could be a key factor for myogenesis. 
   Another effect of different ditch widths was the number of myotubes in one ditch. 
Shimizu et al. (2010) reported that the number of myotubes was decreased in proportion 
to the ditch width, for example, 0.7, 1.1, 1.6 and 3.6 myotubes were present in 30 µm, 
50 µm, 100 µm, and 200 µm width lines 4 days after the induction of differentiation 
[Shimizu et al., 2010]. Molnar et al. (2007) also noted that a single myotube was formed 
in the 30 µm width line 5 days after culturing in DM [Molnar et al., 2007]. These data 
were similar to our results. Our results also added that the number of myotubes in one 
ditch decreased in proportion to the culture period; then, the number increased after the 
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10th day (Figure 32). 
   During the myotube stage, myotubes increased their thickness until the 10th day and 
decreased their orientation angles. After the 10th day, myotubes underwent atrophy and 
aggregated myotubes detached from the culture dish (Figure 33). According to their 
morphological features, including myotube width distribution, orientation angles, and 
shape, myotube growth patterns could be categorized into 4 groups: narrow (5 µm and 
10 µm), medium (25 µm and 50 µm), wide (200 µm and 400 µm), and flat control 
(Figure 13, 14, 15, 16, 17, and 18). 
   In the narrow group, myotubes fused over PVA pattern ridges and increased their 
orientation angles in proportion to the culture period. Generally, there were many 
narrow myotubes, for example between 5 µm and 10 µm, and only few thick ones. The 
myotubes were connected horizontally and expanded in a cteno shaped myotube mass 
(Figure 19d). Due to these features, the myotubes formed a mesh and pectinate shaped 
muscle, similar to cardiac muscle structures; therefore, the narrow sections might be 
useful for transplantation to the heart or for the culture of cardiomyocytes.  
   In the medium width patterns (25 µm and 50 µm width patterns), medium width 
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myotubes were formed with, fewer branches, and high myogenin expression (Figure 15, 
16, 17, 18, 25, 26, 28, 29, and 30). In addition, the number of myotubes in this group 
was very low (Figure 32). If similar width straight myotubes are necessary for 
transplantation, a 25 µm or 50 µm pattern could be used. Also, by using myotubes 
expressing high levels of myogenin, in vitro skeletal muscle regeneration can succeed. 
   In the wider patterns (200 µm and 400 µm width patterns), myotubes of various 
widths existed in one ditch (Figure 15, 16, 17, 18, and 32). In particular, the 400 µm 
width pattern produced very thick myotubes (> 100 µm) (Figure 31). In addition, the 
number of myotubes decreased in proportion to the culture period (Figure 30). The 
decrease in myotube number is likely caused by myotube fusion. During myogenesis, 
myotubes along the PVA ridges extended and fused diagonally to the opposite ditch 
wall at first (Figure 34a). Then, the thin myotubes grew to form an S-shaped figure 
(Figure 34b). During myotube maturation, there would be contractive tension at each 
end of the ditch that probably allowed for the well-aligned myotubes. If a small number 
of thick myotubes surrounded by many thin ones are necessary for an experiment, such 
as skeletal muscle transplantation, the myotubes from a 200 µm or 400 µm pattern on 
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the 7th to 10th days could be useful. Also on the 4th day, many thin myotubes with 
fewer branches were observed and could be useful for transplantation. 
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Figure 9. PVA micropattern preparation and experimental scheme. After covering AzPhPVA on a cut 
TCP plate, the local AzPhPVA section, which is exposed to UV through photomask slit, was fixed and 
patterned into PVA. The remaining AzPhPVA was washed away, and L6 myoblasts were cultured in 
differentiation medium. 
 
 
 
Figure 10. The method used to measure the myotube orientation angle and width. After staining the 
myotube by anti myosin IgG with TRITC, the baseline diagonal to the PVA pattern was drawn. For the 
measurement of myotube orientation angle, myotube-baseline contact angles were measured (a). For the 
myotube width measurement, the width of myotubes that passed the baseline was measured (b).  
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Figure 11. Myosin-TRITC (red, a), Myogenin – Alexa Fluor® 488 (green, b, d), Nucleus  
Hoeches33342 (blue, c), and F-actin – Alexa Fluor® 555 (red, d) stained myotubes in a 400 µm width 
ditch on the 7th day from seeding. Myogenin was expressed around on day 4 (d). Myogenin expression 
rate was calculated as: [(number of myogenin expressing nucleus (b)) ÷ (number of every nucleus (c))] × 
100%. The scale bar represents 100 µm. 
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Figure 12: Micropatterned PVA with ditch and ridge patterns of 400 µm (a), 200 µm (b), 50 µm (c), 25 
µm (d), 10 µm (e), and 5 µm (f). The average height of the PVA coat was about 50 nm, as calculated by 
AFM measurement. 
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Figure 13. Cultured myoblasts in differentiation medium on the flat surface culture plate. The myoblasts 
orientated randomly on the 4th day (a). After differentiation, the myotubes were aligned randomly on the 
7th day (b). The myoblasts were stained with Alexa Fluor® 555 Phalloidin (a), and myotubes were stained 
with anti - skeletal muscle myosin - TRITC (b). The scale bar represents 1000 µm.   
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Figure 14. Cultured myoblasts in differentiation medium on the flat surface culture plate on the 10th (a) 
and the 14th days (b). Myotubes became thick, keeping their random orientation (a, b). On the 14th day, 
aggregation of myotubes was observed (b). The myotubes were stained with anti - skeletal muscle myosin 
- TRITC (a, b). The scale bar represents 1000 µm. 
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Figure15a. Fluorescent micrograph of myotube on a patterned plate on the 4th Day. Myotubes were 
stained with MHC with TRITC. Myoblasts started fusing together to form myotubes expressing MHC. 
The scale bar represents 1000 µm. 
Chapter 2 
 73 
 
Figure15b-g. Fluorescent micrograph of a myotubes on a patterned plate on the 4th day. Myotubes were 
stained with MHC with TRITC. b, c, d, e, f, and g demonstrate myoblasts or myotubes in 400 µm, 200 
µm, 50 µm, 25 µm, 10 µm, and 5 µm wide patterns. Myoblasts began fusing together to form myotubes 
and were expressing MHC. The scale bar represents 100 µm. 
Chapter 2 
 74 
 
Figure16a. Fluorescent micrograph of a myotubes on a patterned plate on the 4th day. Myotubes were 
stained by MHC with TRITC. Myotubes had matured and formed aligned structures. The scale bar 
represents 1000 µm. 
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Figure 16b-g. Fluorescent micrograph of a myotubes on a patterned plate on the 7th day. Myotubes were 
stained by MHC with TRITC. b, c, d, e, f, and g demonstrate myoblasts or myotubes in 400 µm, 200 µm, 
50 µm, 25 µm, 10 µm, and 5 µm wide patterns respectively. The myotubes on the 7th day fused to the 
neighboring myoblasts and myotubes in the 5 µm and 10 µm patterns. The scale bar represents 100 µm. 
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Figure17a. Fluorescent micrograph of a myotubes on a patterned plate on the 10th Day. Myotubes were 
stained by MHC with TRITC. Myotubes were thickening and aggregating. The scale bar represents 1000 
µm. 
Chapter 2 
 77 
 
Figure 17b-g. Fluorescent micrograph of a myotubes on a patterned plate on the 10th day. Myotubes were 
stained by MHC with TRITC. b, c, d, e, f, and g demonstrate myoblasts or myotubes in 400 µm, 200 µm, 
50 µm, 25 µm, 10 µm, and 5 µm wide patterns respectively. Myotubes were thickening and aggregating. 
The scale bar represents 100 µm. 
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Figure18a. Fluorescent micrograph of a myotubes on a patterned plate on the 14th day. Myotubes were 
stained by MHC with TRITC. Myotubes were aggregating and were atrophied. The scale bar represents 
1000 µm. 
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Figure 18b-g. Fluorescent micrograph of a myotubes on a patterned plate on the 14th day. Myotubes were 
stained by MHC with TRITC. b, c, d, e, f, and g demonstrate myoblasts or myotubes in 400 µm, 200 µm, 
50 µm, 25 µm, 10 µm, and 5 µm wide patterns respectively. Myotubes were aggregating and were 
atrophied. The scale bar represents 100 µm. 
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Figure 19. Four types of myotubes in a 200 µm width ditch on the 10th day. The thin fiber shape (a), 
thick fiber shape (b), nodular shape (c), and comb shape (d) myotubes are shown. The myotubes were 
stained by MHC with TRITC. 
 
 
 
Figure 20. Myotubes on the 2nd day. The myotubes in the 10 µm and 25 µm patterned were packed. In 
the 5 µm pattern, myotubes proliferated over the PVA ridges. 
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Figure 21. Myoblast Orientation Angle on Day 1. Myoblasts in the flat surface and wide patterns, 
including the 200µm and 400µm patterns, showed higher orientation angles during the myoblast stage. 
The total number of myotubes was 2250. Data are presented as the means ± the standard error of the 
mean (SEM). *, **. and *** represent p < 0.05, p < 0.01, and p < 0.005, respectively.  
Chapter 2 
 82 
 
Figure 22. Myoblast Orientation Angle on Day 2. Myoblasts in the flat surface and wide patterns, such as 
the 200µm and 400µm patterns, showed higher orientation angles during the myoblast stage. The total 
number of myotubes was 3524. Data are presented as mean ± standard error of the mean (SEM). *, **, 
and *** refer to p < 0.05, p < 0.01, and p < 0.005, respectively. 
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Figure 23. Myoblast Orientation Angle on Day 3. Myoblasts in the flat surface and wide patterns, such as 
the 200µm and 400µm patterns, showed higher orientation angles during the myoblast stage. The total 
number of myotubes was 3960. Data are presented as the mean ± standard error of the mean (SEM). *, **, 
and *** refer to p < 0.05, p < 0.01, and p < 0.005, respectively. 
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Figure 24. Myoblasts around the side and center areas in a ditch. The orientation of cells and F-actins 
were different depending on where the cell was located in a ditch. The F-actin was stained with Phalloidin 
– Alexa Fluor® 488 (green). The nucleus was stained with Hoechst 33342 (blue). 
 
 
 
Figure 25. The “side” and “center” myoblast orientation angles on days 1 to 3. In both the 200 µm and 
400 µm width ditches, the myoblasts around the PVA wall aligned, and their orientation angles decreased 
in proportion to their culture period. However, the orientation angles of the myoblasts around the center 
areas were high in both the 200 µm and 400 µm width ditches, and the “center” myoblasts in the 200 µm 
width ditch decreased their orientation angle more than the “center” myoblasts in the 400 µm width ditch. 
Data are presented as the mean ± standard error of the mean (SEM).  
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Figure 26. Myotube orientation angle on day 4 (a) and 7 (b). The total numbers of myotubes in each 
group on the 4th and 7th days were 1610 and 2383, respectively. Data are presented as the mean ± 
standard error of the mean (SEM). The *, **, and *** refer to p < 0.05, p < 0.01, and p < 0.005, 
respectively. 
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Figure 27. Myotube orientation angle on days 10 (a) and 14 (b). The total numbers of myotubes in each 
group on the 10th and 14th days were 1757 and 1040, respectively. Data are presented as the mean ± 
standard error of the mean (SEM). The *, **, and *** refer to p < 0.05, p < 0.01, and p < 0.005, 
respectively. 
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Figure 28. Myoblast proliferation rate between the 1st and 2nd days (a) and between the 2nd and 3rd days 
(b) (n=140 for each graph). Between the 1st and 2nd days, ANOVA and Turkey tests did not show 
significant differences between any groups (a). Between the 2nd and 3rd days, significant differences 
were observed (b). The proliferation rates of cells in the 5 µm, 200 µm, 400 µm, and flat patterns 
increased at a greater rate than the cells in the 10 µm, 25 µm, and 5 µm patterns. Data are presented as 
mean ± standard error of the mean (SEM). The *, **, and *** refer to p < 0.05, p < 0.01, and p < 0.005, 
respectively. 
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Figure 29. Myogenin expression rate on the 4th (a), and 7th days (b) (n=140 for each group) Data are 
presented as mean ± standard error of the mean (SEM). The *, **, and *** refer to p < 0.05, p < 0.01, and 
p < 0.005, respectively. 
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Figure 30. Myogenin expression rate on the 10th (a), and 14th days (b) (n=140 for each group). Data are 
presented as mean ± standard error of the mean (SEM). The *, **, and *** refer to p < 0.05, p < 0.01, and 
p < 0.005, respectively. 
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Figure 31. Average myotube width in each pattern (a) and the fifty thickest myotube average widths (b). 
In the wide ditches (200 µm and 400 µm), many thin fibers existed and decreased the average width. 
When the fifty thickest myotubes were used, the averages showed results similar to the observed cell 
morphology. Data are presented as mean ± standard error of the mean (SEM).  
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Figure 32. Average myotube number in one ditch for the 7th and 10th days. The Y-axis represents the 
number of myotubes. The myotubes in the 5 µm and 10 µm patterns fused to neighboring ditches; as a 
result, it was impossible to detect the adulate myotube numbers. Data are presented as mean ± standard 
error of the mean (SEM). The *, **, and *** refer to p < 0.05, p < 0.01, and p < 0.005, respectively. 
 
 
Figure 33. Myotube in the 200 µm width ditch. Myoblasts fused together between the 4th and 7th days. 
Then, myotubes matured between the 7th and 10th days. Myotubes atrophied after the 14th day. 
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Figure 34. Myoblasts on the 3rd day (a) and myotubes on the 7th day (b) in the 400 µm width ditch. The 
myotubes along the PVA edge aligned well on the 3rd day. Then the myoblasts fused together as shown 
by the dotted lines (a) and formed myotubes diagonally (b). The scale bars represent 200 µm. 
  
a b 
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Chapter 3 
Three Dimensional Aligned Myotube Culture in Collagen Hydrogel on a Patterned 
Calcium Alginate Gel Substrate 
3.1. Introduction 
   The purpose of this study was the construction of an aligned myotube sheet that 
could patch the hole of a diaphragmatic hernia. This remedy targets recurrent 
diaphragmatic hernia patients who have already received prosthetic patch surgery. 
Prosthetic patches have saved many lives; however, the patch material is difficult to 
merge with the patient’s tissues and can cause a recurrent CDH. If an aligned skeletal 
muscle cell sheet is used to repair the hernia, it could be fused to the patient’s tissue and 
regenerate the diaphragm. However, the diaphragm consists of skeletal muscle where 
the fibers are aligned and generate tension in one direction. In addition, a thick layer is 
necessary to withstand such tension. To overcome these two difficulties, the production 
of a cell-containing hydrogel on a line pattern substrate was postulated. 
   The patterned substrate was made of calcium alginate, which does not attach to 
cells; therefore, the myotubes and hydrogels were easily detached from the substrate for 
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transplantation. Moreover, this type of substrate does not interrupt myotube contractions. 
In addition, it is a safe material that conveys oxygen and nutrients to the cells, even 
those residing directly in contact with the substrate base. Calcium alginate is a 
biodegradable material, and has therefore been used as a scaffold and dressing [Park et 
al., 2013; Skórkowska-Telichowska, et al., 2013]. A ditch pattern on the substrate was 
used to organize the orientation angle of the myoblasts. In Chapter 2’s study, “Aligned 
Poly Vinyl Alcohol Micro Pattern Effect on Myogenesis”, we demonstrated that the 400 
µm width ditch pattern could make many thin aligned myotubes with few thick straight 
myotubes. The 25 µm and 50 µm width pattern produced straighter myotubes than the 
wider pattern. However, since the diaphragm is constantly contracting, it was 
determined that the thick myotubes would be better suited for the purpose of 
diaphragmatic hernia repair. The myoblasts were embedded into the collagen gel and 
proliferated in three dimensions. This allowed the production of larger numbers of 
myotubes than seeding onto a flat surface. It is known that collagen enhances 
myogenesis [Hauschka et al., 1966]. In addition, collagen plays a role in the activation 
of platelets to reinforce the target area with fibrin; therefore collagen is used as a 
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homeostatic and wound healing dressing [Swaim et al., 2000; Sedlarik et al., 1992; 
Schwope et al., 1997]. This feature should be useful in the treatment of diaphragmatic 
hernia, in particular for the prevention of the relapse due to bleeding. 
 
3.2. Materials and Methods 
3.2.1. Calcium Alginate Gel Sheet Preparation 
   First, 40 glass 500 µm diameter rods (Fjiston, Japan) were adhered to two slide 
glasses in a parallel formation (Matsunami, Japan) with silicone glue to make a press 
mold set (Figure 35). One glass slide acted as a tray, while the other acted as a lid. After 
washing the mold sets in milli-Q water, two pieces of 2 cm × 4 cm paraffin film 
(American National Can, USA) were set on each ends of glass bars as a spacer in the 
slide acting as a tray (Figure 35). On the glass bars between the paraffin films, 1 ml of 
3% (w/v) sodium alginate solution (Kimika, Japan) was spread (Figure 35). Then, the 
slide acting as a lid was placed on top, and the ends of the slides were clamped together 
with small clamps (Figure 35). After wiping away excess sodium alginate solution, the 
molds were soaked in 5% (w/v) calcium chloride solution (Wako, Japan) for 3 minutes 
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to allow a cross linking reaction to take place: 
(NaC6H7O6)n  CaCl2 → (C12H14CaO12)n 
Next, 100% isopropanol (Wako, Japan) was sprayed onto the mold set (Figure 36) to 
dehydrate the gel; thus toughening and sterilizing it. Next, the gel was soaked in Hank’s 
Balanced Salt Solution (+) (HBSS (+); Wako, Japan) for 15 min at room temperature to 
remove the isopropanol from the substrate (Figure 35). The width and depth of the 
prepared substrate ditches were measured with Image J (National Institute of Health, 
USA).  
 
3.2.2. Preparation of Collagen Gel Embedded Culture Method 
   First, 8 ml of 0.3% Cellmatrix® Type I-A collagen solution (Nitta Gelatin Inc, 
Japan) was gently mixed with 1 ml tenfold Ham's F12 Medium (Nitta Gelatin Inc, 
Japan) on ice. Next, on ice, the collagen mixture was neutralized with 1 ml of buffer 
solution, containing 1 ml 0.05 N calcium hydroxide, 0.22 g sodium bicarbonate, and 
0.477 g HEPES (Nitta Gelatin Inc, Japan). Then, 200 µl of horse serum (Gibco, USA), 
1 µl of 25 mM insulin (Sigma, USA), and 100 µm penicillin-streptomycin (Wako, 
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Japan) were added into the mixture solution on ice. Two hundred µl of 1×105 L6 
myoblasts / ml suspension (ATCC, USA) in the collagen mixture solution was poured 
on the prepared calcium alginate substrate. To maintain the position of the gel, excess 
gel was allowed to seep out at the ends of the substrate ditches and attach to the dish. 
The collagen gel with the myoblasts on the alginate substrate was incubated for 30 min 
at 37 to allow gelation to occur. Finally, differentiation medium containing DMEM 
F-12 Ham (Sigma-Aldrich, USA), 2% horse serum (Gibco, USA), 1% 
penicillin-streptomycin (Wako, Japan), and 0.01% 25 mM insulin (Sigma-Aldrich, 
USA), was added to the dish.  The cells were then cultured in an incubator at 37 
with 5% CO2. The medium was changed every other day (Figure 35). 
 
3.2.3. Immunofluorescent Staining 
   The hydrogel sheets on the calcium alginate substrate were fixed in 4% 
paraformaldehyde (Wako, Japan) for 20 min at room temperature. The calcium alginate 
substrate was removed by shaking the dish. Next, the samples were permeabilized with 
Triton X-100 (Wako, Japan) for 5 min at 4. Ten percent albumin from bovine serum 
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Cohn Fraction V (BSA; Wako, Japan) was used as a blocker for 10 min at room 
temperature. The samples were then treated with the following antibodies for 60 min at 
room temperature: mouse anti-myosin heavy chain antibody (1:50; Calbiochem, 
Germany), mouse anti-α-sarcomeric actin antibody (1:50; Sigma-Aldrich, USA), or 
mouse anti-desmin (1:50; Sigma, USA). Next, a TRITC-conjugated polyclonal rabbit 
anti-mouse antibody was applied for 60 min at room temperature (1:30; 
DakoCytomation, Denmark). Nuclei were stained with Hoechest 33342 (AnaSpec Inc, 
USA). Finally, the samples were sealed with Fluor Save Reagent (Calbiochem, USA) 
and micro cover glasses (Matsunami, Japan). Between each step, the specimens were 
washed with Dulbecco’s PBS (-) (Nissui, Japan) for 15 min. Finally, the stained 
specimens were visualized using a BZ-9000 fluorescent microscope (the wavelength 
used was 500 nm for TRITC and 372 nm for DAPI; Keyence, Japan) and a 
BZ-Analyzer (Keyence, Japan). 
 
3.2.3. Cell Orientation Angle Analysis 
   From the 1st, 3rd, 5th, 7th, 10th, and 14th days, 300 cells were picked at random 
Chapter 3 
 99 
and then the angle of each cell was measured using Image J (National Institute of Health, 
USA). The cell orientation angles were calculated with the following equation:  
(Cell Orientation Angle) = | (Angle of Cell) – (Angle of Substrate’s ditch) | 
The results were analyzed with a one-way analysis of variance (ANOVA), followed by 
a parametric multiple comparison using Statcell (The publisher OMS Ltd, Japan, p < 
0.05). 
 
3.3. Results 
3.3.1. Patterned Calcium Alginate Substrate and Collagen Hydrogel Embedded 
Culture Method 
   The calcium alginate substrate was successfully created (Figure 36). This substrate 
contained concave ditches with triangular ridges (Figure 36). The average pattern width 
between the tops of the triangular walls was 403.32 µm (standard deviation: SD = 40.01 
µm). The average distance between the bottom of the ditch and the top of the ridge was 
123.60 µm (SD = 20.74 µm). 
   The gelation of the collagen gel on the calcium alginate substrate succeeded (Figure 
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37 and 38). The sheet formed aligned wavy patterns due to the wavy patterned calcium 
alginate substrate mold. The gels in the scaffold ditches were thicker than those on the 
ridges. In the gel, the cells grew in three dimensions. 
  
3.3.2. Immunofluorescent Staining 
   The cells in the hydrogel sheet were stained with anti α-sarcomeric actin antibody, 
anti-desmin antibody, and anti skeletal muscle myosin heavy chain antibody (Figure 39, 
40, and 41). In the myoblast stage, cells do not express sarcomeric actin and myosin 
heavy chain. These results implied that the cells differentiated into skeletal muscle 
related cells, such as myotubes. Sarcomeres were not observed; therefore, the skeletal 
muscle fibers were not yet formed. 
   Immunofluorescent staining also demonstrated that both the cells and their 
cytoskeletons aligned along the calcium alginate substrate pattern (Figure 39, 40, and 
41). The myosin staining showed the shape of the myotubes, and the cells were aligned 
well along the substrate patterns (Figure 41). This phenomenon occurred in both thick 
and thin wavy collagen hydrogel areas (Figure 41). The immunofluorescent staining 
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also demonstrated that both the microfilament (-sarcomeric actin) and intermediate 
filament (desmin) aligned well in the collagen hydrogel sheet (Figure 39 and 40).  
 
3.3.3. Myoblast and Myotube Orientation Angle  
On the patterned substrate, hydrogel sheet containing the aligned myoblasts and 
myotubes were successfully formed. The cells aligned well in proportion to their culture 
period (Figure 42). The orientation angles of the cells on the 1st, 3rd, 5th, 7th, 10th, and 
14th days were 24.54° (SD = 24.04), 22.27° (SD = 22.26), 10.15° (SD = 11.00), 10.70° 
(SD =10.60), 9.33° (SD = 9.14), and 6.18° (SD = 6.54) (Figure 32), respectively (Figure 
42). The angle on the 14th day was significantly lower than the angle of the 1st day (p < 
0.01), 3rd day (p < 0.01), and 5th day (p < 0.05). In addition, the angles on the 7th and 
10th days were significantly lower than that of the 1st day (p < 0.01) and 3rd day (p < 
0.01) (Figure 42).  
 
3.4. Discussion 
   A well-aligned myotube-containing collagen hydrogel sheet was formed (Figure 38, 
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39, 40, 41, and 42). It is possible that the alignment was controlled by two factors: the 
patterned calcium alginate gel substrate and the one-axis negative tension to the 
hydrogel.  
   First, the line patterned calcium alginate substrate probably aligned the myotubes. 
The patterned calcium alginate substrate was constructed with ditches 403.32 µm in 
width and 123.60 µm in ridge height. The substrate ditch molded the rod-shaped 
hydrogel, and the rods were covered with the flat hydrogel sheet (Figure 38). It has 
previously been reported that culturing myoblasts in a straight groove led to the 
formation of aligned myoblasts and myotubes [Shen et al., 2006]. This is similar to the 
myoblasts found in the ditches in Chapter 2' study. Furthermore in another study, even 
though the myoblasts were only present on the pattern lines, which were narrower than 
the myoblasts, they could form aligned myotubes [Shimizu et al., 2009; Wang et al., 
2010]. The myotubes in the connective cover area were located on the substrate’s ridges, 
and the line shaped stimulus probably caused the aligned myotubes. The previous study 
using a PVA aligned pattern demonstrated that even a wide pattern, such as 400 µm 
width patterns, could produce aligned myotubes (Figure 24, 25, 26 and 27).  
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   Second, tension must be the other factor contributing to align the myotubes. The 
myoblast-containing hydrogel was fixed on the culture dish at two points; one on each 
end (Figure 43). The hydrogel shrunk during its gelation period (Figure 43). The gel 
could not adhere to the calcium alginate substrate; therefore, the hydrogel slid on the 
substrate and was pulled toward each end (Figure 43). At the same time, the cells were 
pushed in towards the center (Figure 43). As a result of these two tensions, cells were 
distorted into an oval shape. These two types of tension are supposed to occur during 
the myotube period because myotubes usually contract. The result of the decreased cell 
orientation angle in proportion to the culture period implied this two tension hypothesis. 
The cell orientation angles in this study were lower than those in the previous study 
using patterned PVA. The cells on the PVA aligned pattern were exposed to pressure 
from the PVA ridges. However, every cell in the PVA study could adhere to the ditch 
area. This would lead to less pulling tension in comparison with the present study. 
   The next step is transplantation of the aligned myotube-containing hydrogel sheet in 
vivo. The myotubes were three dimensionally distributed in the gel; as a result, the sheet 
is likely to be tougher than a single cell layer. In addition, collagen adheres to, and 
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activates platelets [Swaim et al., 2000; Sedlarik et al., 1992; Schwope et al., 1997]. Thus 
the fibrin formation was enhanced, and the sheet itself was reinforced. This function 
should be helpful in closing the hole in diaphragmatic hernia cases. Relapse of the 
diaphragmatic hernia tends to cause massive bleeding. Therefore, the role of a 
hemostatic agent can be useful. However, the tension of the diaphragm is strong. 
Therefore, transplanting several layers of sheets is optimal.  
   For further improvement of the collagen embedded myotube sheet, mixing growth 
factors, myostatin suppressing protein, or myostatin suppressing siRNA into the 
hydrogel, or seeding other cells on the hydrogel may be useful in transplantation. The 
purpose of using growth factor is improving the transplanted cell survival rate. 
Candidate growth factors are basic fibroblast growth factor (bFGF), hepatocyte growth 
factor (HGF), and vascular endothelial growth factor (VEGF). The effect of bFGF on 
the improvement of transplanted myoblast survival and the enhancement of myogenesis 
in the target area were observed in a previous study [Hagiwara et al., 2013]. An 
angiogenic effect was also reported [Price et al., 2007; Nakajima, et al., 2004; 
Sakakibara, et al., 2002]. The diaphragm is constantly contracting; therefore, its muscles 
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require a large amount of oxygen. As such, without angiogenesis, the transplanted cells 
will die. HGF is also effective for early stage of myogenesis. Satellite cells express 
HGF, and the growth factor has a role in regulating myogenesis [Hayashi et al., 2004; 
Tatsumi et al., 2002]. Injecting HGF into the damaged muscle area activated the resting 
satellite cells; however, there is a report that long term HGF administration suppressed 
myoblast differentiation both in vitro and in vivo [Miller et al., 2000]. HGF also has a 
role in angiogenesis [Marui et al., 2005]. If HGF were to be tested, a short releasing 
period should be safe for transplantation. To enhance the vasculogenesis and 
angiogenesis, VEGF should be very effective [Best et al., 2013].  
   In addition to using growth factors, suppressing myostatin expression may be useful. 
When myostatin expression is interrupted, myogenin expression increases, and myotube 
formation and muscle hypertrophy are induced. For myostatin suppression, follistatin 
recombinant administration into mdx mice demonstrated preferable effects on muscle 
dystrophy [Nakatani et al., 2008]. Also, injecting myostatin suppressing siRNA 
increased the muscle mass in the whole body [Kinouchi et al., 2008]. 
   Another possible improvement is seeding endothelial cells for angiogenesis or 
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neural stem cells for neurogenesis on the hydrogel sheet, since both blood vessels and 
neurons are necessary for skeletal muscle function and survival. 
  
 
 
 
Figure 35. Simple scheme of the creation of the aligned collagen gel embedded culture system. A 3% 
sodium alginate solution was sandwiched between glass molds and cross-linked using a 5% calcium 
chloride solution into a calcium alginate substrate. Then, the collagen gel solution containing myoblasts 
was added to the substrate. Next, gelation was achieved by incubation at 37 for 30 min, then the 
differentiation medium was added into the dish, and the myoblasts in the gel on the substrate were 
cultured in an incubator at 37 with 5% CO2. 
 
 
 
Figure 36. Bright field pictures of the calcium alginate gel substrate. The substrate was patterned with 
aligned triangular ridges and concave ditches (a, b, c). The bright thin lines with thin shadow lines are the 
triangular ridges, and the lines between ridges are concave ditches. The average ditch width was 403.32 
µm (SD = 40.01 µm) and the average distance between the bottom of the ditch and the top of the ridge 
was 123.60 µm (SD = 20.74). The scale bars represent 500 µm. 
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Figure 37. Myoblast embedded collagen gel on the patterned calcium alginate gel substrate. The gels with 
myoblasts were distributed in the ditches of the substrate. 
 
 
 
Figure 38. Myotube embedded collagen hydrogel sheet on the 14th day. The sheet was fixed with 4% 
paraformaldehyde for 20 min. The calcium alginate substrate was removed during the fixation process. 
The wavy patterns are clearly demonstrated. During cell culture, the sheet shrunk into a dog-bone shape. 
The scale bar represents 5 mm. 
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Figure 39. The hydrogel sheet on the 14th day. The cells were stained with anti α-sarcomeric actin with 
TRITC (red color). The sheet formed aligned wavy patterns (top figure). The gels in the scaffold ditches 
were thicker than those on the ridges. The cytoskeletons were aligned well (bottom figure). The scale bar 
represents 300 µm. 
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Figure 40. Low magnification (top) and high magnification (bottom) images of the myotube embedded 
collagen hydrogel sheet on the 14th day (top and bottom). The cells were stained with mouse anti desmin 
and anti mouse-TRITC (red color). These pictures imply that the intermediate fiber (desmin) aligned well 
in the collagen hydrogel on the wavy pattern calcium alginate substrate. The scale bar represents 100 µm. 
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Figure 41. The MHC-TRITC stained hydrogel sheet on the 14th day. The top and bottom pictures 
represent the same location at different magnifications. The myotubes in both ridge (top) and groove 
(bottom) areas aligned well. In addition, the existence of MHC proved that the cells differentiated into 
myotubes. The scale bar represents 100 µm. 
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Figure 42. Average cell orientation angle for each sample day. The cells on the 5th day were significantly 
well aligned in comparison with those from the 3rd day. To determine the orientation angle, for each 
sample day, 300 cells were measured using Image J. Data are presented as mean ± the standard deviation. 
The * and ** represent p < 0.05 and p < 0.01, respectively. 
 
 
Figure 43. Diagram of myoblast-containing hydrogel. The hydrogel was fixed on the culture dish in the 
blue circle areas. During gelation, the hydrogel shrank, creating a pulling force (blue arrow). Then, 
spontaneously, the hydrogel was distorted in towards the center (red arrow), creating a dog-bone structure. 
These two axis tensions are supposed to occur during myogenesis, and are caused by myotube 
contraction. 
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Conclusion 
   Through these studies, the myoblast survival rate was improved by using bFGF, and 
the ditched-pattern width effects on aligned myotube formation were verified; then, an 
aligned myotube-containing hydrogel sheet was created. 
   The controlled and sustained release of bFGF from gelatin hydrogel microspheres 
not only improved the cell survival rate during myoblast transplantation but also 
promoted muscle regeneration following muscle damage. These effects were mainly 
associated with myogenesis, rather than the angiogenic actions of bFGF. In addition, 
after 10 months, surviving transplanted cells were observed, particularly in the 
experimental group, through fluorescent microscopy and qRT-PCR. This drug delivery 
system thus increases the efficiency of muscle regeneration after myoblast 
transplantation. 
   Myogenesis and the transplanted cell survival rate were improved through the 
controlled release of bFGF, but the numbers of GFP-positive skeletal muscle and cells 
remained high. This might be due to the transplanted cells having moved or been 
washed away from their target area. To remedy this, myotubes, which do not move, 
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were considered for use in transplantation. However, differentiation culture of 
myoblasts into myotubes on a normal culture dish produced randomly orientated 
myotubes, with features very different to naturally aligned skeletal muscle fibers. It is 
known that culturing myoblasts on aligned ditches can produce aligned myotubes, but 
the pattern width effects on myogenesis were unknown. Therefore, aligned ditch 
patterns containing different widths were made, and their effect on myogenesis was 
studied.  
   The aligned PVA patterned plate successfully aligned myotubes in every width 
pattern, although the pattern width affected some features of the myotubes, such as their 
orientation angle, myogenin expression, and shape. In the narrow width sections (5 µm 
and 10 µm) net-like branched myotubes were formed. In the medium sections (25 µm 
and 50 µm) less branched, straight, highly myogenin-expressing myotubes were formed. 
In the wide sections (200 µm and 400 µm), a mixture of a few very thick and many thin 
myotubes appeared.  
   After the effect of pattern width was demonstrated, the construction of an aligned 
myotube sheet began. For transplantation, many myotubes would be necessary to take 
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over the recipient skeletal muscle function. Therefore, the 400 µm width ditch, which 
was found to produce thick myotubes in the previous study, was chosen to make an 
aligned myotube sheet. However, a single-layer myotube sheet is unlikely to be able to 
tolerate the pressure of the diaphragm. As a result, the production of a three dimensional, 
thick layer of aligned myotubes cultured in a hydrogel sheet was considered. Collagen 
hydrogel was used in order to add mechanical strength and provide tensional stress for 
myoblasts and myotubes during differentiation. To align the myotubes, a 400 µm width 
ditch containing substrate was made from calcium alginate, and then a cell-containing 
collagen hydrogel was cultured on it. The calcium alginate does not adhere to cells and 
collagen; therefore, it did not interrupt the hydrogel tension on the cells. It also allowed 
oxygen and nutrients to pass to the cells located in the bottom of the hydrogel. 
   The patterned calcium alginate substrate was used with a collagen gel embedded 
three-dimensional culture method and an aligned myotube-containing hydrogel sheet 
was formed. The myoblasts and myotubes aligned in proportion to the culture period. 
The cells aligned better than those on the PVA patterned plate. This result is probably 
due to two factors: First, the ditch pattern stimulated the cells to form a string shape. 
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Second, since the gel did not adhere to the substrate, the cells were exposed to the 
pulling tension from the shrinking of the hydrogel, further creating an environment for 
alignment. As a result, a three dimensionally aligned myotube-containing collagen 
hydrogel sheet was successfully constructed. 
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Future Plan 
   Through this research, the usefulness of myoblast transplantation with bFGF 
released by gelatin hydrogel microspheres was revealed. The transplanted myoblasts 
differentiated into skeletal muscle and survived for 10 months in the skeletal muscle of 
rat hind limbs. In addition, the bFGF enhanced myogenesis in the host skeletal muscle 
and increased the amount of CD31, implying angiogenesis. If the mixture of a patient’s 
myoblasts and bFGF with the gelatin hydrogel microsphere can be injected around the 
artificial patch used for diaphragmatic hernia treatment, the diaphragm may increase its 
size while the patient grows, and this method may contribute to decreasing the 
recurrence of diaphragmatic hernia. 
   The aligned PVA patterned substrate study showed how ditch width affected 
myotube formation. The myotube morphological changes throughout the culture period 
gave an indication of the optimal time for transplantation. This width pattern effect 
study must be applied to the development of a three-dimensional hydrogel cell culture 
method for transplantation. 
   The method of culturing a myoblast embedded gel on a calcium alginate substrate 
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succeeded in producing an aligned myotube-containing collagen hydrogel sheet in vitro. 
The hydrogel sheet contains many layers of myotubes. The collagen should also activate 
platelets and be reinforced by fibrin in vivo. However, the tension of the diaphragm is 
strong; therefore, using several layers of this aligned myotube containing hydrogel sheet 
should be optimal for the next step; an in vivo transplantation to rat diaphragm or 
skeletal muscle. For the in vivo study, the use of growth factors (bFGF, HGF, or VEGF), 
recombinant myostatin suppressing follistatin or myostatin suppressing siRNA with the 
aligned myotube containing hydrogel sheet should be useful. Also, transplanting the 
hydrogel sheet with endothelial cells and neural stem cells should be useful to build a 
blood vessel and neural network around the target area to further support the 
transplanted myotubes. After optimizing this transplantation method, it could be used in 
clinical treatments using myoblasts or satellite cells from patient muscle tissue, 
umbilical cord blood, bone marrow, or induced pluripotent stem cells (iPS). 
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Glossary 
 
Abbreviation English Japanese 
Alexa Fluor® 488 Green fluorescent label ÐÜâaªí 
Alexa Fluor® 555 
Phalloidin 
Red fluorescent labell binding phalloidin. 
The phalloidin binds to filamentous 
actin. 
ïÜâaÜÊªíZ	@R,S  
@R,S F-Actin Ã
ËØyĆ¨é¡ 
- sarcomeric 
actin 
-skeletal or -cardiac muscle 
cytoskeletal protein 
Ć¨ÆÆzËØĆ
¨áÀî 
ANOVA Analysis of Variance h h¥ 
AzPhPVA Azido Phenol Poly Vinyl Alcohol 
,8@ ;UPGO?:UPP
)UP 
BSA Bovine Serum Albumin +ä³PAIS 
-Actin Also known as ACTB (actin beta). jv&3SDU1(ACTB)  
bFGF Basic Fibroblast Growth Factor ÄÑÏÝËØ¬x 
C Control group ­ñÕ 
Calcium 
Alginate 
Water-insoluble substance made by 
mixing sodium alginate to calcium 
containing solution. 
P%Sø97OJ#P+J
µ±²tg¤®Wµ
·î 
CD31 
Endothelial cell adhesion molecule 
Also, it is known as PECAM-1 
äÇcÁËØ¿¸ÛczÈ
áÀîjvPECAM-1 
CDH Congenital Diaphragmatic Hernia `«ÿÛCP: 
DDW Deionized Distilled Water "Sþrß½® 
CT Delta delta Ct analysis Âùê¥¯Ct­ñ¯ 
DAPI 
4',6-diamidino-2-phenylindole 
DNA binding blue fluorescent label 
,I,;@ :PS8UP 
DNAÍtĀÜâaÜÊ 
Desmin 
Intermediate filament (mainly in muscle 
related cells and tissues) 
XýÉ@NKS7 
ÆËØTÌÔ¿¸ 
DM Differentiation Medium hpì~ă± 
DMEM Dulbecco's modified Eagle medium 2PD4)¯U'P~{ 
DDS Drug delivery system à·òó+-5J 
DDS Gel(s) Drug delivery system gel à·òó+-5J(P 
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ECMO Extracorporeal Membrane Oxygenation \Û|× 
EDTA Ethylenediaminetetraacetic acid !3QS,ISwöø 
EGFP Enhanced Green Fluorescent Protein ćÐÜâaáÀî 
Ex Experimental group ąÕ 
F-Actin 
Filamentous Actin 
One of the cytoskeleton having linear 
micro filament shape in a cell. 
@NKS7&3S 
ËØĆ¨©H&R@N
KS7VÅ 
FGF-2 Fibroblast Growth Factor-2 ÓÏÝËØ¬x-2 
FK506 
Tacrolimus 
Immunosuppresive agent 
1&ROJ-  
b¾km 
FITC Fluorescein isothiocyanate ÐÜâaªí 
Follistatin Activin binding antagonist &3?SÍtáÀî 
GAPDH 
Glyceraldehyde 3-phosphate 
dehydrogenase 
'O.PP6>8 3OSøÚ®Ê÷
Ê 
GFP Green Fluorescent Protein ÐÜâaáÀî 
GM Growth Medium û»~{ 
HBSS Hank's Balanced Salt Solution <S&-çµ± 
HE stain Hematoxylin-Eosin stain CH7$+OST!",S¦Ü 
HGF Hepatocyte growth factor ÖËØ¬x 
Hoechst33342 DNA binding blue fluorescent label 
C$-7 33342 
ËØ§¦Ü»ĀÜâaÜÊ 
HS Horse serum Hä³ 
ImageJ Image processing program ¼_f¹0@7  
iPS Induced pluripotent stem cell YÙËØ 
Kyplot Statistical analysis software Îëê¥0@7  
MB (s) 
Myoblast(s) 
Muscle precursor cell(s) 
ÆÝËØ 
ÆlĄËØ 
mdx mouse Muscle dystrophy model mouse Æ,-7R@UL6PH- 
MRF(s) 
Myogenic regulatory factor 
MyoD, Myf5, Myogenin, MRF4 
Æqkx 
MyoD, Myf5, Myogenin, MRF4 
Mrf4 Myogenic regulatory factor 4 Æqkx 4 
Mrf5 Myogenic regulatory factor 5 Æqkx 5 
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MSC(s) Mesenchymal Stem Cell(s) ýÞÉËØ 
Myogenin 
Myogenic factor 4 
Expressing during myoblast fusion to 
make myotubes and muscle 
development. 
H", :SI"(:S 
Ækx 
ÆÝËØãt¢Ć¨ÆûT^
¢
¿¸ 
Myostatin 
Muscle differentiation and growth 
inhibitor 
Interrupting myogenin expression 
I"-13S 
Ć¨Æ¬kx 
Myogenin¿¸k 
MT(s) 
Myotube(s) 
Multi nucleus cell made by myoblast 
fusion. 
ÆÇËØ 
ÆÝËØuãtg¤
§ËØ 
MT stain Masson’s Trichrome stain H40S7O&RUJ¦Ü 
MyoD 
Muscle differentiation  
regulatory transcription factor. 
Expressing during myoblast proliferation 
and satellite cell differentiation into 
myoblast. 
Ć¨Æðdx 
ÆÝËØ¬¢°n£å
ºËØÆÝËØhp¢

¿¸ 
Pax7 
Paired Box Transcription Factor 
Expressing in satellite cell 
EU8F4&-ðdx 7 
ÆåºËØ¿¸ 
PBS Phosphate-buffered saline OSøÒæĂ® 
PVA Poly Vinyl Alcohol GO?:PP)UP 
O.C.T. 
Compound 
Compound: Optimal Cutting 
Temperature Compound 
eÍÌÔi¶]è»o}m 
PCR Polymerase chain reaction GOKNU/õús¯ 
PS Penicillin streptomycin E:+OS-7QB7H+S 
RT-PCT 
Reverse transcriptase-polymerase  
chain reaction 
ôðdGOKNU/õús¯ 
RT-qPCR 
Quantitative reverse transcriptase 
-polymerase chain reaction 
ùôðdGOKNU/õús¯ 
SC(s) Satellite Cell(s) åºËØ 
siRNA Small interfering RNA [h´ RNA 
SD Sprague-Dawley -BNU'8UO 
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üú)R:UÉN47Å 
Sodium Alginate Water-soluble polysaccharide  
P%Sø97OJpP%S
ø®µÈā 
Statcel Statistical analysis software Îëê¥0@7  
TRITC 
Tetramethylrhodamine-5-(and 6) 
-isothiocyanate 
ïÜâaªí 
UPL Universal Prove Library M:=U*PBRUANANOU 
VEGF Vascular endothelial growth factor äÇcÁ¬x 
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